| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.692 | 0.003 | 0.692 | GABA C receptor rho-3 antagonist | 0.579 0.01 CID_15366 0.503 0.025 CID_148175 0.674 0.004 CID_11376 | ||
| 0.673 | 0.003 | 0.675 | Peroxidase inhibitor | 0.46 0.013 CID_15366 0.443 0.015 CID_148175 0.675 0.003 CID_11376 | CID_11376 | |
| 0.692 | 0.025 | 0.779 | Caspase 9 stimulant | 0.396 0.113 CID_15366 0.779 0.014 CID_148175 0.606 0.035 CID_11376 | CID_148175 | |
| 0.611 | 0.003 | 0.611 | Porphobilinogen synthase inhibitor | 0.269 0.006 CID_15366 0.178 0.015 CID_148175 0.482 0.004 CID_11376 | ||
| 0.603 | 0.014 | 0.603 | 5 Hydroxytryptamine release stimulant | 0.328 0.062 CID_15366 0.415 0.043 CID_148175 0.594 0.015 CID_11376 | ||
| 0.572 | 0.011 | 0.572 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.478 0.044 CID_15366 0.445 0.065 CID_148175 0.425 0.08 CID_11376 | ||
| 0.56 | 0.009 | 0.56 | Superoxide dismutase inhibitor | 0.324 0.043 CID_15366 0.243 0.079 CID_148175 0.49 0.014 CID_11376 | ||
| 0.554 | 0.009 | 0.554 | MAP kinase kinase 6 inhibitor | 0.509 0.016 CID_15366 0.302 0.134 CID_148175 0.368 0.079 CID_11376 | ||
| 0.525 | 0.021 | 0.525 | Aryl hydrocarbon receptor agonist | 0.239 0.083 CID_15366 0.144 0.14 CID_148175 0.37 0.043 CID_11376 | ||
| 0.501 | 0.004 | 0.501 | Alcohol oxidase inhibitor | 0.156 0.009 CID_15366 0.111 0.016 CID_148175 0.334 0.004 CID_11376 | ||
| 0.522 | 0.026 | 0.522 | 5 Hydroxytryptamine release inhibitor | 0.353 0.112 CID_15366 0.329 0.135 CID_148175 0.489 0.036 CID_11376 | ||
| 0.523 | 0.03 | 0.654 | Aldehyde oxidase inhibitor | 0.229 0.091 CID_15366 0.213 0.098 CID_148175 0.654 0.012 CID_11376 | CID_11376 | |
| 0.49 | 0.032 | 0.49 | Histamine release inhibitor | 0.262 0.147 CID_15366 0.338 0.105 CID_148175 0.474 0.039 CID_11376 | ||
| 0.435 | 0.014 | 0.435 | Calcium channel activator | 0.343 0.055 CID_15366 0.311 0.081 CID_148175 0.401 0.024 CID_11376 | ||
| 0.431 | 0.022 | 0.506 | Dyrk kinase inhibitor | 0.506 0.013 CID_11376 | CID_11376 | |
| 0.425 | 0.022 | 0.509 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.509 0.012 CID_11376 | CID_11376 | |
| 0.406 | 0.003 | 0.406 | GABA C receptor rho-2 antagonist | 0.254 0.011 CID_15366 0.211 0.023 CID_148175 0.383 0.004 CID_11376 | ||
| 0.401 | 0.019 | 0.401 | Clk dual-specificity kinase inhibitor | 0.394 0.02 CID_11376 | ||
| 0.379 | 0.006 | 0.4 | Growth factor agonist | 0.4 0.005 CID_15366 0.229 0.041 CID_11376 | CID_15366 | |
| 0.366 | 0.004 | 0.366 | Activin receptor-like kinase 4 inhibitor | 0.116 0.057 CID_148175 0.156 0.026 CID_11376 | ||
| 0.37 | 0.01 | 0.394 | NOS3 expression enhancer | 0.136 0.088 CID_148175 0.394 0.008 CID_11376 | CID_11376 | |
| 0.377 | 0.017 | 0.377 | CDC-like kinase 4 inhibitor | 0.15 0.101 CID_15366 0.335 0.024 CID_11376 | ||
| 0.438 | 0.084 | 0.438 | MAP kinase 1 inhibitor | 0.302 0.177 CID_148175 0.314 0.166 CID_11376 | ||
| 0.381 | 0.033 | 0.499 | DNA damaging | 0.499 0.014 CID_15366 0.355 0.039 CID_148175 0.445 0.02 CID_11376 | CID_15366 | |
| 0.37 | 0.027 | 0.37 | Pyruvate kinase inhibitor | 0.238 0.065 CID_15366 0.351 0.033 CID_11376 | ||
| 0.342 | 0.004 | 0.342 | MAP kinase kinase 3 inhibitor | 0.244 0.038 CID_15366 0.242 0.04 CID_148175 0.237 0.046 CID_11376 | ||
| 0.359 | 0.023 | 0.359 | 5 Hydroxytryptamine uptake stimulant | 0.269 0.064 CID_15366 0.266 0.066 CID_148175 0.324 0.034 CID_11376 | ||
| 0.384 | 0.06 | 0.45 | Vasodilator, peripheral | 0.45 0.041 CID_15366 0.198 0.179 CID_148175 0.325 0.085 CID_11376 | CID_15366 | |
| 0.356 | 0.034 | 0.356 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.297 0.067 CID_11376 | ||
| 0.332 | 0.011 | 0.379 | Neurotrophic factor enhancer | 0.191 0.086 CID_15366 0.237 0.047 CID_148175 0.379 0.007 CID_11376 | CID_11376 | |
| 0.346 | 0.027 | 0.346 | Death-associated protein kinase 3 inhibitor | 0.245 0.054 CID_11376 | ||
| 0.32 | 0.004 | 0.32 | CYP2A6 inhibitor | 0.145 0.018 CID_15366 0.158 0.014 CID_148175 0.141 0.019 CID_11376 | ||
| 0.34 | 0.026 | 0.34 | EphB2 antagonist | 0.169 0.112 CID_11376 | ||
| 0.34 | 0.028 | 0.34 | Cyclic AMP phosphodiesterase inhibitor | 0.186 0.105 CID_148175 0.297 0.043 CID_11376 | ||
| 0.329 | 0.019 | 0.337 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.337 0.018 CID_11376 | CID_11376 | |
| 0.328 | 0.021 | 0.328 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.135 0.134 CID_15366 0.316 0.023 CID_11376 | ||
| 0.31 | 0.004 | 0.31 | Phenylalanine 4-hydroxylase inhibitor | 0.115 0.02 CID_15366 0.114 0.02 CID_148175 0.262 0.005 CID_11376 | ||
| 0.329 | 0.025 | 0.371 | CDC-like kinase 2 inhibitor | 0.371 0.017 CID_11376 | CID_11376 | |
| 0.305 | 0.01 | 0.354 | Nitric-oxide synthase stimulant | 0.354 0.005 CID_15366 0.263 0.025 CID_148175 0.339 0.005 CID_11376 | CID_15366 | |
| 0.296 | 0.004 | 0.296 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.124 0.011 CID_15366 0.187 0.007 CID_148175 0.199 0.007 CID_11376 | ||
| 0.338 | 0.049 | 0.338 | Hypoxia-inducible factor 1 alpha inhibitor | 0.187 0.168 CID_15366 0.265 0.088 CID_148175 0.318 0.057 CID_11376 | ||
| 0.302 | 0.015 | 0.336 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.336 0.009 CID_11376 | CID_11376 | |
| 0.308 | 0.022 | 0.308 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.192 0.19 CID_148175 0.221 0.114 CID_11376 | ||
| 0.328 | 0.043 | 0.328 | Insulysin inhibitor | 0.31 0.052 CID_15366 0.302 0.058 CID_11376 | ||
| 0.291 | 0.006 | 0.291 | Mannose-6-phosphate isomerase inhibitor | 0.198 0.032 CID_15366 0.179 0.043 CID_148175 0.254 0.011 CID_11376 | ||
| 0.29 | 0.008 | 0.29 | Ferrochelatase inhibitor | 0.163 0.033 CID_15366 0.112 0.06 CID_148175 0.194 0.024 CID_11376 | ||
| 0.272 | 0.004 | 0.272 | GABA C receptor rho-1 antagonist | 0.166 0.015 CID_15366 0.137 0.028 CID_148175 0.246 0.004 CID_11376 | ||
| 0.299 | 0.034 | 0.299 | Gastrin inhibitor | 0.211 0.133 CID_15366 0.251 0.078 CID_11376 | ||
| 0.271 | 0.009 | 0.271 | 5 Hydroxytryptamine 3E antagonist | 0.241 0.02 CID_15366 0.202 0.059 CID_148175 0.226 0.031 CID_11376 | ||
| 0.285 | 0.027 | 0.285 | Protein kinase C nu inhibitor | 0.191 0.051 CID_11376 | ||
| 0.263 | 0.005 | 0.263 | GABA C receptor antagonist | 0.155 0.027 CID_15366 0.149 0.03 CID_148175 0.252 0.006 CID_11376 | ||
| 0.294 | 0.036 | 0.316 | Tyrosine 3 hydroxylase inhibitor | 0.283 0.043 CID_15366 0.19 0.155 CID_148175 0.316 0.026 CID_11376 | CID_11376 | |
| 0.259 | 0.003 | 0.259 | Aconitate hydratase inhibitor | 0.106 0.008 CID_15366 0.11 0.007 CID_148175 0.141 0.004 CID_11376 | ||
| 0.268 | 0.013 | 0.312 | Cystathionine beta-synthase inhibitor | 0.143 0.044 CID_15366 0.161 0.036 CID_148175 0.312 0.009 CID_11376 | CID_11376 | |
| 0.292 | 0.038 | 0.511 | Platelet aggregation inhibitor | 0.511 0.009 CID_15366 0.165 0.112 CID_11376 | CID_15366 | |
| 0.271 | 0.019 | 0.271 | 3C-like protease (Human coronavirus) inhibitor | 0.178 0.066 CID_15366 0.225 0.039 CID_11376 | ||
| 0.358 | 0.111 | 0.414 | Calcium channel L-type activator | 0.301 0.157 CID_15366 0.414 0.072 CID_11376 | CID_11376 | |
| 0.323 | 0.077 | 0.328 | Cholesterol antagonist | 0.328 0.075 CID_15366 0.257 0.12 CID_148175 0.293 0.096 CID_11376 | CID_15366 | |
| 0.258 | 0.014 | 0.258 | Cyclin-dependent kinase 3 inhibitor | 0.148 0.101 CID_148175 0.174 0.055 CID_11376 | ||
| 0.28 | 0.036 | 0.28 | RNA-directed DNA polymerase inhibitor | 0.222 0.072 CID_15366 0.205 0.093 CID_148175 0.248 0.051 CID_11376 | ||
| 0.284 | 0.041 | 0.284 | 5 Hydroxytryptamine 1E antagonist | 0.233 0.093 CID_15366 0.248 0.077 CID_11376 | ||
| 0.289 | 0.046 | 0.289 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.184 0.085 CID_11376 | ||
| 0.261 | 0.019 | 0.261 | Toll-Like receptor 9 antagonist | 0.184 0.043 CID_15366 0.151 0.062 CID_11376 | ||
| 0.255 | 0.013 | 0.255 | GABA C receptor agonist | 0.175 0.026 CID_15366 0.114 0.054 CID_148175 0.244 0.014 CID_11376 | ||
| 0.258 | 0.016 | 0.266 | CDC-like kinase 1 inhibitor | 0.266 0.015 CID_11376 | CID_11376 | |
| 0.305 | 0.063 | 0.305 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.191 0.105 CID_15366 0.256 0.076 CID_11376 | ||
| 0.265 | 0.027 | 0.265 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.154 0.063 CID_11376 | ||
| 0.239 | 0.004 | 0.239 | Acetylcholine release stimulant | 0.137 0.027 CID_15366 0.14 0.024 CID_148175 0.138 0.025 CID_11376 | ||
| 0.275 | 0.044 | 0.275 | MAP kinase kinase 2 inhibitor | 0.241 0.058 CID_11376 | ||
| 0.234 | 0.004 | 0.234 | Histamine N-methyltransferase inhibitor | 0.114 0.034 CID_15366 0.137 0.019 CID_148175 0.166 0.01 CID_11376 | ||
| 0.315 | 0.085 | 0.32 | Angiogenesis inhibitor | 0.32 0.083 CID_148175 0.195 0.176 CID_11376 | CID_148175 | |
| 0.248 | 0.021 | 0.248 | Activin receptor-like kinase 2 inhibitor | 0.111 0.108 CID_148175 0.239 0.023 CID_11376 | ||
| 0.239 | 0.013 | 0.239 | MAP kinase 12 inhibitor | 0.18 0.029 CID_15366 0.115 0.076 CID_11376 | ||
| 0.252 | 0.027 | 0.252 | Protein kinase (CK1) gamma 3 inhibitor | 0.227 0.034 CID_11376 | ||
| 0.246 | 0.023 | 0.438 | Phosphodiesterase inhibitor | 0.438 0.005 CID_15366 0.13 0.072 CID_11376 | CID_15366 | |
| 0.28 | 0.059 | 0.28 | Interleukin agonist | 0.204 0.117 CID_15366 0.243 0.084 CID_11376 | ||
| 0.3 | 0.079 | 0.373 | Caspase 3 stimulant | 0.373 0.052 CID_148175 0.278 0.091 CID_11376 | CID_148175 | |
| 0.239 | 0.018 | 0.239 | Toll-Like receptor antagonist | 0.182 0.037 CID_11376 | ||
| 0.223 | 0.003 | 0.223 | Granulocyte macrophage colony stimulating factor agonist | 0.128 0.011 CID_15366 0.13 0.011 CID_148175 0.202 0.003 CID_11376 | ||
| 0.268 | 0.048 | 0.268 | MAP-kinase-activated kinase 5 inhibitor | 0.183 0.127 CID_11376 | ||
| 0.232 | 0.012 | 0.232 | Nav1.6 sodium channel blocker | 0.111 0.11 CID_148175 0.18 0.028 CID_11376 | ||
| 0.255 | 0.035 | 0.255 | LIM domain kinase 1 inhibitor | 0.222 0.053 CID_11376 | ||
| 0.254 | 0.035 | 0.254 | Focal adhesion kinase 2 inhibitor | 0.196 0.072 CID_11376 | ||
| 0.236 | 0.019 | 0.342 | Platelet activating factor antagonist | 0.342 0.008 CID_15366 0.108 0.072 CID_148175 | CID_15366 | |
| 0.262 | 0.044 | 0.262 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.158 0.088 CID_11376 | ||
| 0.229 | 0.013 | 0.229 | GABA receptor agonist | 0.168 0.028 CID_15366 0.142 0.04 CID_11376 | ||
| 0.235 | 0.018 | 0.263 | Glutamate receptor antagonist | 0.226 0.02 CID_15366 0.263 0.014 CID_11376 | CID_11376 | |
| 0.261 | 0.046 | 0.261 | Anesthetic general | 0.151 0.113 CID_15366 0.209 0.07 CID_11376 | ||
| 0.243 | 0.029 | 0.251 | Heat shock protein 90 alpha antagonist | 0.251 0.026 CID_15366 0.217 0.04 CID_148175 0.209 0.044 CID_11376 | CID_15366 | |
| 0.221 | 0.008 | 0.297 | Stem cell growth factor agonist | 0.297 0.005 CID_15366 | CID_15366 | |
| 0.22 | 0.008 | 0.22 | Hepatocyte growth factor antagonist | 0.196 0.012 CID_11376 | ||
| 0.215 | 0.005 | 0.215 | Toll-Like receptor 3 antagonist | 0.104 0.045 CID_15366 0.108 0.04 CID_148175 | ||
| 0.324 | 0.115 | 0.324 | 15-Lipoxygenase inhibitor | 0.301 0.132 CID_15366 0.316 0.121 CID_11376 | ||
| 0.245 | 0.036 | 0.245 | Growth factor antagonist | 0.146 0.072 CID_11376 | ||
| 0.219 | 0.01 | 0.283 | Alcohol dehydrogenase inhibitor | 0.095 0.058 CID_15366 0.283 0.005 CID_11376 | CID_11376 | |
| 0.227 | 0.019 | 0.227 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.12 0.045 CID_11376 | ||
| 0.218 | 0.01 | 0.218 | 5 Hydroxytryptamine 3A agonist | 0.158 0.031 CID_15366 0.185 0.02 CID_11376 | ||
| 0.219 | 0.013 | 0.238 | CF transmembrane conductance regulator agonist | 0.152 0.072 CID_15366 0.137 0.102 CID_148175 0.238 0.008 CID_11376 | CID_11376 | |
| 0.225 | 0.02 | 0.225 | DNA intercalator | 0.188 0.029 CID_11376 | ||
| 0.218 | 0.014 | 0.218 | Platelet activating factor alpha antagonist | 0.128 0.04 CID_11376 | ||
| 0.239 | 0.034 | 0.252 | Tumour necrosis factor antagonist | 0.252 0.03 CID_15366 0.179 0.068 CID_11376 | CID_15366 | |
| 0.244 | 0.041 | 0.244 | I kappa B kinase epsilon inhibitor | 0.189 0.081 CID_11376 | ||
| 0.225 | 0.022 | 0.253 | Aldehyde dehydrogenase inhibitor | 0.121 0.069 CID_15366 0.253 0.017 CID_11376 | CID_11376 | |
| 0.207 | 0.005 | 0.207 | MAP-kinase-activated kinase inhibitor | 0.157 0.013 CID_11376 | ||
| 0.23 | 0.028 | 0.23 | Cytokine production inhibitor | 0.121 0.088 CID_11376 | ||
| 0.235 | 0.033 | 0.237 | Histone acetyltransferase inhibitor | 0.237 0.032 CID_15366 0.202 0.067 CID_11376 | CID_15366 | |
| 0.235 | 0.034 | 0.235 | Cytidine deaminase inhibitor | 0.119 0.102 CID_15366 | ||
| 0.246 | 0.046 | 0.246 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.232 0.051 CID_11376 | ||
| 0.21 | 0.01 | 0.21 | Protein kinase C mu inhibitor | 0.123 0.04 CID_11376 | ||
| 0.249 | 0.051 | 0.249 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.228 0.06 CID_11376 | ||
| 0.223 | 0.026 | 0.223 | Glycogen synthase kinase-3 inhibitor | 0.09 0.089 CID_11376 | ||
| 0.221 | 0.025 | 0.221 | Interleukin 1 antagonist | |||
| 0.223 | 0.028 | 0.223 | Alpha-N-acetylglucosaminidase inhibitor | 0.172 0.044 CID_15366 0.139 0.062 CID_148175 0.196 0.035 CID_11376 | ||
| 0.218 | 0.025 | 0.218 | Glycogen synthase kinase-3 beta inhibitor | 0.093 0.087 CID_11376 | ||
| 0.208 | 0.014 | 0.228 | Beta amyloid protein antagonist | 0.228 0.01 CID_148175 0.179 0.024 CID_11376 | CID_148175 | |
| 0.283 | 0.09 | 0.295 | 12-Lipoxygenase inhibitor | 0.295 0.083 CID_11376 | CID_11376 | |
| 0.202 | 0.01 | 0.202 | Glutamate (mGluR) antagonist | 0.074 0.055 CID_15366 0.083 0.047 CID_11376 | ||
| 0.225 | 0.033 | 0.225 | Vascular endothelial growth factor 3 antagonist | 0.124 0.091 CID_11376 | ||
| 0.209 | 0.019 | 0.209 | MAP kinase 13 inhibitor | 0.14 0.041 CID_15366 | ||
| 0.2 | 0.01 | 0.2 | GABA A receptor agonist | 0.124 0.022 CID_15366 0.103 0.035 CID_11376 | ||
| 0.215 | 0.027 | 0.215 | Cyclin-dependent kinase 8 inhibitor | 0.142 0.088 CID_15366 0.123 0.113 CID_148175 0.21 0.029 CID_11376 | ||
| 0.192 | 0.005 | 0.192 | MAP-kinase-activated kinase 2 inhibitor | 0.146 0.012 CID_11376 | ||
| 0.264 | 0.08 | 0.264 | Ca(v)3.3 blocker | |||
| 0.218 | 0.035 | 0.218 | Protein kinase (CK1) inhibitor | 0.148 0.069 CID_11376 | ||
| 0.221 | 0.038 | 0.221 | Protein kinase (CK1) gamma inhibitor | 0.187 0.049 CID_11376 | ||
| 0.192 | 0.01 | 0.192 | Platelet growth factor antagonist | 0.145 0.021 CID_11376 | ||
| 0.196 | 0.015 | 0.196 | Protein kinase C gamma inhibitor | 0.147 0.033 CID_15366 0.191 0.016 CID_11376 | ||
| 0.209 | 0.029 | 0.209 | Death-associated protein kinase 2 inhibitor | 0.155 0.096 CID_15366 0.178 0.057 CID_11376 | ||
| 0.182 | 0.005 | 0.182 | Transforming growth factor antagonist | 0.097 0.023 CID_11376 | ||
| 0.185 | 0.009 | 0.185 | Glutamate (mGluR group I) antagonist | 0.073 0.045 CID_15366 | ||
| 0.229 | 0.053 | 0.292 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.292 0.026 CID_15366 0.24 0.047 CID_11376 | CID_15366 | |
| 0.213 | 0.038 | 0.213 | Protein kinase (CK1) gamma 1 inhibitor | 0.165 0.058 CID_11376 | ||
| 0.207 | 0.032 | 0.207 | Neurotensin receptor agonist | 0.147 0.108 CID_15366 0.207 0.031 CID_11376 | ||
| 0.268 | 0.093 | 0.366 | Nootropic | 0.366 0.049 CID_15366 | CID_15366 | |
| 0.185 | 0.013 | 0.397 | Creatine kinase inhibitor | 0.159 0.02 CID_15366 0.101 0.058 CID_148175 0.397 0.003 CID_11376 | CID_11376 | |
| 0.196 | 0.024 | 0.196 | Cathepsin H inhibitor | 0.156 0.042 CID_15366 0.119 0.076 CID_148175 0.13 0.063 CID_11376 | ||
| 0.266 | 0.094 | 0.266 | Streptokinase A inhibitor | 0.184 0.143 CID_15366 0.231 0.115 CID_11376 | ||
| 0.185 | 0.014 | 0.185 | TRPA1 agonist | 0.1 0.088 CID_15366 0.178 0.016 CID_11376 | ||
| 0.23 | 0.06 | 0.23 | DNA methylase inhibitor | 0.223 0.064 CID_11376 | ||
| 0.181 | 0.011 | 0.181 | Heat shock protein 70 antagonist | 0.138 0.081 CID_15366 0.135 0.094 CID_148175 0.164 0.023 CID_11376 | ||
| 0.198 | 0.03 | 0.198 | Sodium channel (voltage-gated) blocker | 0.135 0.068 CID_11376 | ||
| 0.193 | 0.027 | 0.193 | MAP kinase 3 inhibitor | 0.143 0.079 CID_11376 | ||
| 0.205 | 0.04 | 0.205 | Glycogen synthase kinase-3 alpha inhibitor | 0.164 0.057 CID_11376 | ||
| 0.2 | 0.035 | 0.207 | Hexokinase inhibitor | 0.207 0.031 CID_11376 | CID_11376 | |
| 0.187 | 0.026 | 0.187 | Antibacterial (Helicobacter pylori) | 0.167 0.034 CID_15366 0.178 0.029 CID_11376 | ||
| 0.18 | 0.019 | 0.18 | Interleukin 8 antagonist | 0.133 0.047 CID_15366 0.155 0.031 CID_11376 | ||
| 0.168 | 0.007 | 0.168 | Lanosterol 14 alpha demethylase inhibitor | 0.122 0.029 CID_15366 0.106 0.048 CID_148175 0.128 0.023 CID_11376 | ||
| 0.178 | 0.02 | 0.178 | Pregnane X receptor agonist | 0.135 0.087 CID_15366 0.159 0.039 CID_148175 0.168 0.028 CID_11376 | ||
| 0.203 | 0.046 | 0.233 | Succinate dehydrogenase inhibitor | 0.188 0.059 CID_15366 0.155 0.103 CID_148175 0.233 0.029 CID_11376 | CID_11376 | |
| 0.192 | 0.034 | 0.192 | Protein kinase (CK1) gamma 2 inhibitor | 0.181 0.038 CID_11376 | ||
| 0.16 | 0.005 | 0.16 | Phosphodiesterase X inhibitor | 0.052 0.026 CID_11376 | ||
| 0.16 | 0.005 | 0.16 | Phosphodiesterase 10A inhibitor | 0.052 0.026 CID_11376 | ||
| 0.16 | 0.005 | 0.188 | AMPA receptor antagonist | 0.188 0.005 CID_15366 0.125 0.008 CID_11376 | CID_15366 | |
| 0.173 | 0.018 | 0.173 | Gastric antisecretory | 0.12 0.042 CID_15366 0.098 0.068 CID_148175 0.098 0.068 CID_11376 | ||
| 0.222 | 0.069 | 0.396 | ErbB-1 antagonist | 0.396 0.016 CID_148175 0.231 0.063 CID_11376 | CID_148175 | |
| 0.158 | 0.005 | 0.158 | 5 Hydroxytryptamine 3 agonist | 0.069 0.036 CID_15366 0.063 0.044 CID_148175 0.092 0.019 CID_11376 | ||
| 0.172 | 0.02 | 0.172 | Photosensitizer | 0.102 0.085 CID_15366 0.108 0.075 CID_148175 0.169 0.022 CID_11376 | ||
| 0.193 | 0.042 | 0.198 | Heat shock protein 90 antagonist | 0.176 0.051 CID_15366 0.198 0.039 CID_148175 0.18 0.049 CID_11376 | CID_148175 | |
| 0.184 | 0.035 | 0.184 | Protein kinase (CK1) delta inhibitor | 0.163 0.045 CID_11376 | ||
| 0.213 | 0.063 | 0.219 | DNA methyltransferase I inhibitor | 0.219 0.06 CID_11376 | CID_11376 | |
| 0.181 | 0.032 | 0.181 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.129 0.118 CID_11376 | ||
| 0.267 | 0.118 | 0.38 | Vasodilator, coronary | 0.38 0.042 CID_15366 0.271 0.113 CID_148175 0.236 0.148 CID_11376 | CID_15366 | |
| 0.177 | 0.029 | 0.195 | Cyclin-dependent kinase 5 inhibitor | 0.195 0.024 CID_11376 | CID_11376 | |
| 0.166 | 0.018 | 0.166 | Hedgehog signaling inhibitor | |||
| 0.16 | 0.013 | 0.255 | Macrophage migration inhibitory factor inhibitor | 0.255 0.005 CID_11376 | CID_11376 | |
| 0.162 | 0.017 | 0.197 | Protein kinase C zeta inhibitor | 0.092 0.062 CID_15366 0.197 0.012 CID_11376 | CID_11376 | |
| 0.188 | 0.045 | 0.2 | Arachidonic acid antagonist | 0.159 0.078 CID_15366 0.176 0.058 CID_148175 0.2 0.033 CID_11376 | CID_11376 | |
| 0.148 | 0.005 | 0.148 | Glutamate (mGluR group III) agonist | 0.047 0.026 CID_148175 0.044 0.029 CID_11376 | ||
| 0.163 | 0.02 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.154 0.034 CID_15366 0.154 0.034 CID_148175 0.163 0.02 CID_11376 | ||
| 0.189 | 0.047 | 0.25 | ATPase inhibitor | 0.25 0.014 CID_148175 0.18 0.058 CID_11376 | CID_148175 | |
| 0.158 | 0.016 | 0.158 | Pim-3 kinase inhibitor | 0.105 0.04 CID_11376 | ||
| 0.208 | 0.066 | 0.208 | Tyrosine kinase inhibitor | |||
| 0.225 | 0.084 | 0.245 | Antiamyloidogenic | 0.241 0.075 CID_148175 0.245 0.073 CID_11376 | CID_11376 | |
| 0.161 | 0.02 | 0.18 | Beta glucuronidase inhibitor | 0.097 0.075 CID_15366 0.095 0.078 CID_148175 0.18 0.015 CID_11376 | CID_11376 | |
| 0.144 | 0.003 | 0.144 | Glutamate (mGluR7) antagonist | 0.111 0.006 CID_15366 0.104 0.009 CID_148175 0.114 0.005 CID_11376 | ||
| 0.149 | 0.009 | 0.149 | Bromodomain-containing protein 2 inhibitor | 0.106 0.034 CID_11376 | ||
| 0.14 | 0.004 | 0.14 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.095 0.018 CID_15366 0.091 0.021 CID_148175 0.11 0.009 CID_11376 | ||
| 0.163 | 0.028 | 0.163 | Polo-like kinase-4 inhibitor | 0.12 0.056 CID_15366 0.104 0.073 CID_11376 | ||
| 0.151 | 0.017 | 0.151 | Acetylcholine nicotinic agonist | 0.074 0.065 CID_15366 0.132 0.022 CID_11376 | ||
| 0.16 | 0.026 | 0.175 | UDP-glucose 4-epimerase inhibitor | 0.149 0.029 CID_15366 0.125 0.04 CID_148175 0.175 0.022 CID_11376 | CID_11376 | |
| 0.143 | 0.009 | 0.143 | Nicotinic alpha4beta2 receptor antagonist | 0.067 0.066 CID_15366 0.075 0.055 CID_148175 0.111 0.023 CID_11376 | ||
| 0.139 | 0.006 | 0.139 | Transforming growth factor beta 3 antagonist | |||
| 0.143 | 0.01 | 0.143 | Histone deacetylase stimulant | 0.095 0.031 CID_11376 | ||
| 0.143 | 0.01 | 0.143 | Histone deacetylase SIRT1 stimulant | 0.095 0.031 CID_11376 | ||
| 0.151 | 0.019 | 0.151 | Electrolyte absorption antagonist | 0.09 0.075 CID_15366 0.103 0.054 CID_11376 | ||
| 0.152 | 0.021 | 0.152 | Transcription factor STAT6 inhibitor | 0.109 0.083 CID_15366 0.137 0.035 CID_11376 | ||
| 0.158 | 0.029 | 0.158 | Death-associated protein kinase 1 inhibitor | |||
| 0.139 | 0.01 | 0.196 | Benzodiazepine agonist | 0.196 0.004 CID_15366 0.067 0.055 CID_11376 | CID_15366 | |
| 0.211 | 0.082 | 0.289 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.289 0.043 CID_11376 | CID_11376 | |
| 0.138 | 0.01 | 0.138 | Protein kinase B beta inhibitor | 0.107 0.021 CID_11376 | ||
| 0.174 | 0.046 | 0.174 | Vascular endothelial growth factor antagonist | |||
| 0.161 | 0.033 | 0.162 | Aminopeptidase B inhibitor | 0.162 0.033 CID_15366 0.125 0.05 CID_11376 | CID_15366 | |
| 0.135 | 0.008 | 0.144 | Glutamate (mGluR1) antagonist | 0.144 0.007 CID_15366 | CID_15366 | |
| 0.229 | 0.103 | 0.229 | Transcription factor STAT inhibitor | 0.194 0.147 CID_11376 | ||
| 0.16 | 0.034 | 0.16 | Interleukin 1b antagonist | |||
| 0.158 | 0.032 | 0.158 | MAP kinase kinase kinase inhibitor | 0.09 0.077 CID_15366 0.106 0.061 CID_148175 0.135 0.043 CID_11376 | ||
| 0.136 | 0.011 | 0.136 | mTOR complex 2 inhibitor | 0.079 0.071 CID_15366 0.108 0.025 CID_148175 0.122 0.016 CID_11376 | ||
| 0.129 | 0.006 | 0.129 | Aryl hydrocarbon receptor antagonist | 0.087 0.021 CID_11376 | ||
| 0.139 | 0.017 | 0.139 | Vanilloid 1 antagonist | |||
| 0.165 | 0.044 | 0.165 | MAP kinase kinase inhibitor | 0.144 0.055 CID_11376 | ||
| 0.156 | 0.035 | 0.156 | MAP kinase 9 inhibitor | |||
| 0.126 | 0.005 | 0.126 | Phospholipase D inhibitor | 0.079 0.037 CID_15366 0.083 0.03 CID_148175 0.091 0.021 CID_11376 | ||
| 0.192 | 0.072 | 0.192 | TRKC antagonist | |||
| 0.127 | 0.007 | 0.127 | Glutamate (mGluR5) antagonist | |||
| 0.122 | 0.004 | 0.122 | Transcription factor RelA inhibitor | 0.086 0.013 CID_15366 0.085 0.013 CID_148175 0.114 0.004 CID_11376 | ||
| 0.146 | 0.028 | 0.146 | Adenylate kinase inhibitor | 0.127 0.038 CID_15366 0.097 0.073 CID_148175 0.137 0.032 CID_11376 | ||
| 0.146 | 0.029 | 0.146 | Pim-1 kinase inhibitor | |||
| 0.216 | 0.099 | 0.216 | Calpain inhibitor | 0.165 0.155 CID_15366 | ||
| 0.129 | 0.013 | 0.129 | CDC7 inhibitor | 0.072 0.042 CID_11376 | ||
| 0.213 | 0.098 | 0.213 | Neuropeptide Y2 antagonist | |||
| 0.123 | 0.008 | 0.123 | Potassium channel (ATP-sensitive) blocker | 0.123 0.008 CID_15366 0.069 0.042 CID_148175 0.088 0.022 CID_11376 | ||
| 0.122 | 0.007 | 0.122 | Transforming growth factor beta 1 antagonist | 0.062 0.024 CID_11376 | ||
| 0.138 | 0.025 | 0.138 | CDC-like kinase 3 inhibitor | 0.118 0.046 CID_11376 | ||
| 0.162 | 0.05 | 0.162 | Sodium channel blocker | 0.107 0.102 CID_11376 | ||
| 0.123 | 0.011 | 0.123 | Toll-Like receptor 7 antagonist | |||
| 0.146 | 0.035 | 0.151 | DNA repair enzyme inhibitor | 0.123 0.067 CID_15366 0.151 0.03 CID_11376 | CID_11376 | |
| 0.123 | 0.012 | 0.123 | GABA A receptor antagonist | 0.112 0.014 CID_15366 0.058 0.032 CID_11376 | ||
| 0.243 | 0.132 | 0.269 | Transcription factor NF kappa B inhibitor | 0.218 0.152 CID_148175 0.269 0.114 CID_11376 | CID_11376 | |
| 0.143 | 0.031 | 0.143 | Nav1.5 sodium channel blocker | |||
| 0.124 | 0.013 | 0.124 | TRPA1 antagonist | 0.081 0.025 CID_11376 | ||
| 0.14 | 0.029 | 0.14 | HIV-1 integrase (Overall Integration) inhibitor | 0.093 0.061 CID_15366 0.133 0.032 CID_11376 | ||
| 0.163 | 0.052 | 0.163 | Alkaline phosphatase inhibitor | 0.135 0.071 CID_11376 | ||
| 0.126 | 0.015 | 0.126 | Nav1.7 sodium channel blocker | 0.072 0.041 CID_11376 | ||
| 0.157 | 0.047 | 0.157 | Vascular endothelial growth factor 2 antagonist | |||
| 0.134 | 0.024 | 0.134 | MAP kinase kinase 1 inhibitor | 0.09 0.07 CID_15366 0.125 0.031 CID_11376 | ||
| 0.151 | 0.041 | 0.151 | Vascular endothelial growth factor 1 antagonist | |||
| 0.133 | 0.023 | 0.146 | NADH dehydrogenase inhibitor | 0.092 0.053 CID_15366 0.109 0.036 CID_148175 0.146 0.018 CID_11376 | CID_11376 | |
| 0.143 | 0.033 | 0.143 | CC chemokine 6 receptor antagonist | 0.133 0.061 CID_11376 | ||
| 0.164 | 0.054 | 0.164 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.123 0.079 CID_11376 | ||
| 0.114 | 0.004 | 0.114 | Glutamate (mGluR1a) antagonist | 0.041 0.029 CID_11376 | ||
| 0.144 | 0.036 | 0.144 | Cyclin-dependent kinase 9 inhibitor | 0.122 0.044 CID_15366 0.136 0.039 CID_11376 | ||
| 0.158 | 0.05 | 0.172 | NADPH oxidase inhibitor | 0.172 0.044 CID_11376 | CID_11376 | |
| 0.12 | 0.012 | 0.12 | GABA receptor antagonist | 0.104 0.015 CID_15366 0.059 0.033 CID_11376 | ||
| 0.16 | 0.053 | 0.179 | Cyclin-dependent kinase 7 inhibitor | 0.179 0.043 CID_11376 | CID_11376 | |
| 0.132 | 0.025 | 0.145 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.129 0.026 CID_15366 0.077 0.054 CID_148175 0.145 0.02 CID_11376 | CID_11376 | |
| 0.115 | 0.007 | 0.115 | Oleamide hydrolase inhibitor | 0.049 0.028 CID_11376 | ||
| 0.145 | 0.038 | 0.165 | Sphingosine 1-phosphate receptor 4 antagonist | 0.165 0.022 CID_15366 0.118 0.076 CID_11376 | CID_15366 | |
| 0.115 | 0.008 | 0.124 | Topoisomerase II beta inhibitor | 0.124 0.007 CID_11376 | CID_11376 | |
| 0.188 | 0.081 | 0.188 | Non-steroidal antiinflammatory agent | 0.169 0.096 CID_15366 0.144 0.123 CID_11376 | ||
| 0.114 | 0.007 | 0.114 | Botulinum neurotoxin type A inhibitor | 0.053 0.049 CID_15366 0.055 0.046 CID_148175 0.084 0.015 CID_11376 | ||
| 0.113 | 0.006 | 0.113 | Toll-Like receptor 8 antagonist | 0.061 0.03 CID_11376 | ||
| 0.11 | 0.004 | 0.11 | Methionyl aminopeptidase 1 inhibitor | 0.03 0.026 CID_15366 0.034 0.019 CID_148175 0.034 0.018 CID_11376 | ||
| 0.212 | 0.105 | 0.254 | DNA synthesis inhibitor | 0.254 0.064 CID_15366 0.176 0.159 CID_148175 0.212 0.105 CID_11376 | CID_15366 | |
| 0.121 | 0.014 | 0.121 | Caspase 7 inhibitor | 0.096 0.033 CID_11376 | ||
| 0.146 | 0.04 | 0.146 | Alpha 2b adrenoreceptor antagonist | |||
| 0.125 | 0.021 | 0.125 | Phosphodiesterase 6D inhibitor | 0.1 0.052 CID_11376 | ||
| 0.125 | 0.021 | 0.125 | Phosphodiesterase 3A inhibitor | 0.084 0.049 CID_11376 | ||
| 0.123 | 0.019 | 0.123 | Aminopeptidase I inhibitor | 0.078 0.044 CID_15366 0.067 0.058 CID_148175 0.091 0.033 CID_11376 | ||
| 0.123 | 0.02 | 0.123 | Glutamate release inhibitor | 0.101 0.042 CID_148175 0.112 0.028 CID_11376 | ||
| 0.127 | 0.024 | 0.127 | Glutamate receptor agonist | 0.068 0.065 CID_11376 | ||
| 0.133 | 0.03 | 0.154 | Prolactin inhibitor | 0.102 0.053 CID_15366 0.154 0.02 CID_11376 | CID_11376 | |
| 0.155 | 0.053 | 0.162 | MAP kinase kinase 4 inhibitor | 0.162 0.043 CID_11376 | CID_11376 | |
| 0.136 | 0.034 | 0.236 | Carbonic anhydrase III inhibitor | 0.236 0.011 CID_15366 0.153 0.027 CID_11376 | CID_15366 | |
| 0.109 | 0.008 | 0.109 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.094 0.011 CID_11376 | ||
| 0.131 | 0.029 | 0.313 | Phosphodiesterase IV inhibitor | 0.313 0.005 CID_15366 0.102 0.043 CID_11376 | CID_15366 | |
| 0.11 | 0.008 | 0.143 | Fatty acid synthase inhibitor | 0.07 0.025 CID_15366 0.056 0.041 CID_148175 0.143 0.005 CID_11376 | CID_11376 | |
| 0.131 | 0.03 | 0.131 | Protein kinase C delta inhibitor | 0.079 0.078 CID_11376 | ||
| 0.125 | 0.024 | 0.125 | Phosphodiesterase I inhibitor | 0.092 0.056 CID_11376 | ||
| 0.116 | 0.017 | 0.134 | Amidase inhibitor | 0.134 0.012 CID_11376 | CID_11376 | |
| 0.132 | 0.033 | 0.132 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.128 0.035 CID_15366 0.085 0.073 CID_148175 0.112 0.044 CID_11376 | ||
| 0.195 | 0.096 | 0.195 | Potassium channel blocker | |||
| 0.154 | 0.055 | 0.154 | Sphingosine 1-phosphate receptor 5 antagonist | 0.153 0.056 CID_11376 | ||
| 0.11 | 0.012 | 0.11 | Alpha 2 adrenoreceptor agonist | 0.064 0.037 CID_148175 0.061 0.041 CID_11376 | ||
| 0.144 | 0.046 | 0.144 | Protein kinase (CK2) alpha inhibitor | 0.138 0.05 CID_11376 | ||
| 0.128 | 0.031 | 0.154 | Protein kinase A inhibitor | 0.154 0.023 CID_11376 | CID_11376 | |
| 0.103 | 0.006 | 0.103 | Potassium channel small-conductance Ca-activated blocker | 0.054 0.022 CID_11376 | ||
| 0.122 | 0.025 | 0.171 | MAP kinase 11 inhibitor | 0.171 0.013 CID_15366 | CID_15366 | |
| 0.134 | 0.038 | 0.134 | Carbonic anhydrase XV inhibitor | 0.128 0.041 CID_11376 | ||
| 0.123 | 0.027 | 0.123 | Vanilloid antagonist | |||
| 0.1 | 0.004 | 0.1 | Glutamate (mGluR4) agonist | 0.035 0.022 CID_148175 0.035 0.021 CID_11376 | ||
| 0.135 | 0.04 | 0.135 | Protein kinase (CK2) inhibitor | 0.129 0.043 CID_11376 | ||
| 0.116 | 0.021 | 0.116 | CXC chemokine 4 receptor antagonist | |||
| 0.13 | 0.035 | 0.171 | DOPA decarboxylase inhibitor | 0.118 0.047 CID_15366 0.171 0.013 CID_11376 | CID_11376 | |
| 0.153 | 0.058 | 0.164 | Adenylate cyclase stimulant | 0.123 0.117 CID_15366 0.123 0.117 CID_148175 0.164 0.042 CID_11376 | CID_11376 | |
| 0.116 | 0.022 | 0.12 | Myeloperoxidase inhibitor | 0.12 0.02 CID_11376 | CID_11376 | |
| 0.107 | 0.013 | 0.107 | 5 Hydroxytryptamine 3A antagonist | 0.061 0.054 CID_15366 | ||
| 0.143 | 0.049 | 0.143 | Aurora-B kinase inhibitor | 0.123 0.063 CID_11376 | ||
| 0.104 | 0.012 | 0.104 | Protein kinase C beta inhibitor | 0.075 0.038 CID_15366 0.083 0.026 CID_11376 | ||
| 0.103 | 0.011 | 0.103 | Orexin receptor 1 antagonist | 0.067 0.065 CID_11376 | ||
| 0.099 | 0.009 | 0.099 | Potassium channel intermediate-conductance Ca-activated blocker | 0.061 0.04 CID_15366 | ||
| 0.097 | 0.008 | 0.097 | Corticotropin releasing factor 2 receptor antagonist | 0.059 0.049 CID_11376 | ||
| 0.093 | 0.004 | 0.093 | Cytokine production stimulant | 0.049 0.032 CID_15366 0.049 0.032 CID_148175 0.06 0.013 CID_11376 | ||
| 0.166 | 0.078 | 0.168 | Phospholipase C inhibitor | 0.149 0.108 CID_15366 0.168 0.075 CID_11376 | CID_11376 | |
| 0.12 | 0.032 | 0.12 | Triose-phosphate isomerase inhibitor | 0.115 0.036 CID_15366 0.111 0.038 CID_11376 | ||
| 0.243 | 0.155 | 0.243 | Calpain 2 inhibitor | 0.225 0.168 CID_15366 | ||
| 0.116 | 0.028 | 0.623 | MAP kinase 14 inhibitor | 0.623 0.004 CID_15366 | CID_15366 | |
| 0.117 | 0.029 | 0.207 | Phosphodiesterase 4D inhibitor | 0.207 0.01 CID_15366 | CID_15366 | |
| 0.152 | 0.064 | 0.175 | Cell wall synthesis inhibitor | 0.175 0.043 CID_11376 | CID_11376 | |
| 0.151 | 0.064 | 0.204 | Amylase inhibitor | 0.204 0.043 CID_11376 | CID_11376 | |
| 0.097 | 0.011 | 0.097 | Phosphodiesterase 1C inhibitor | 0.072 0.027 CID_11376 | ||
| 0.097 | 0.01 | 0.097 | Phosphodiesterase 1A inhibitor | 0.061 0.04 CID_11376 | ||
| 0.097 | 0.011 | 0.097 | Exportin-1 inhibitor | 0.071 0.041 CID_15366 0.071 0.041 CID_148175 0.067 0.052 CID_11376 | ||
| 0.12 | 0.035 | 0.12 | Interleukin 1 beta converting enzyme inhibitor | 0.101 0.056 CID_11376 | ||
| 0.133 | 0.048 | 0.133 | Aurora-A kinase inhibitor | 0.109 0.06 CID_11376 | ||
| 0.182 | 0.097 | 0.343 | Anticonvulsant | 0.343 0.03 CID_15366 | CID_15366 | |
| 0.263 | 0.178 | 0.263 | Transcription factor inhibitor | |||
| 0.113 | 0.028 | 0.113 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.097 0.042 CID_11376 | ||
| 0.103 | 0.018 | 0.103 | Acetylcholine M5 receptor agonist | 0.058 0.057 CID_11376 | ||
| 0.088 | 0.004 | 0.088 | Alpha 1d adrenoreceptor agonist | 0.049 0.017 CID_15366 0.035 0.032 CID_148175 0.053 0.014 CID_11376 | ||
| 0.116 | 0.033 | 0.116 | Thioredoxin inhibitor | 0.086 0.069 CID_11376 | ||
| 0.094 | 0.012 | 0.094 | Nicotinic alpha7 receptor agonist | 0.048 0.045 CID_15366 | ||
| 0.116 | 0.034 | 0.116 | Glutamate (mGluR7) agonist | |||
| 0.103 | 0.021 | 0.103 | Phosphodiesterase III inhibitor | 0.08 0.035 CID_11376 | ||
| 0.107 | 0.026 | 0.107 | CDK2/cyclin E2 inhibitor | |||
| 0.105 | 0.024 | 0.105 | Adenosine A3 receptor antagonist | 0.069 0.06 CID_11376 | ||
| 0.089 | 0.009 | 0.089 | Glutamate (mGluR5) agonist | |||
| 0.099 | 0.019 | 0.099 | Biliverdin reductase inhibitor | 0.082 0.025 CID_15366 0.066 0.035 CID_11376 | ||
| 0.118 | 0.039 | 0.118 | Phosphodiesterase 7B inhibitor | |||
| 0.094 | 0.015 | 0.094 | Orexin receptor antagonist | |||
| 0.137 | 0.059 | 0.137 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.095 | 0.016 | 0.095 | Pim-2 kinase inhibitor | 0.052 0.041 CID_11376 | ||
| 0.094 | 0.016 | 0.094 | Phosphodiesterase 1B inhibitor | 0.062 0.039 CID_11376 | ||
| 0.105 | 0.028 | 0.134 | Protein kinase B alpha inhibitor | 0.134 0.013 CID_11376 | CID_11376 | |
| 0.095 | 0.018 | 0.108 | MAP kinase kinase 7 inhibitor | 0.073 0.07 CID_15366 0.108 0.007 CID_11376 | CID_11376 | |
| 0.208 | 0.132 | 0.273 | Lipoxygenase inhibitor | 0.273 0.085 CID_15366 0.252 0.099 CID_11376 | CID_15366 | |
| 0.081 | 0.005 | 0.081 | Benzodiazepine antagonist | 0.049 0.03 CID_15366 0.047 0.034 CID_11376 | ||
| 0.156 | 0.079 | 0.156 | Src kinase inhibitor | 0.115 0.113 CID_148175 | ||
| 0.092 | 0.015 | 0.092 | Nicotinic neuronal receptor agonist | 0.068 0.029 CID_11376 | ||
| 0.204 | 0.128 | 0.204 | Transcription factor STAT3 inhibitor | 0.18 0.164 CID_11376 | ||
| 0.122 | 0.046 | 0.122 | Mediator release inhibitor | |||
| 0.152 | 0.076 | 0.165 | Interferon gamma antagonist | 0.165 0.062 CID_148175 0.159 0.067 CID_11376 | CID_148175 | |
| 0.098 | 0.022 | 0.098 | Glycine receptor agonist | 0.077 0.043 CID_148175 0.094 0.025 CID_11376 | ||
| 0.097 | 0.022 | 0.097 | Phosphodiesterase VI inhibitor | 0.074 0.053 CID_11376 | ||
| 0.117 | 0.041 | 0.117 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.144 | 0.069 | 0.144 | MAP3K9 inhibitor | 0.127 0.101 CID_11376 | ||
| 0.126 | 0.052 | 0.228 | Topoisomerase I inhibitor | 0.173 0.034 CID_15366 0.228 0.02 CID_11376 | CID_11376 | |
| 0.087 | 0.013 | 0.087 | Cyclin D1 inhibitor | 0.061 0.042 CID_15366 0.068 0.031 CID_11376 | ||
| 0.09 | 0.017 | 0.09 | 5 Hydroxytryptamine 5 antagonist | 0.054 0.047 CID_11376 | ||
| 0.091 | 0.018 | 0.091 | 5 Hydroxytryptamine 5A antagonist | 0.06 0.044 CID_11376 | ||
| 0.103 | 0.03 | 0.103 | Glycine receptor antagonist | 0.085 0.049 CID_15366 0.077 0.062 CID_148175 0.1 0.032 CID_11376 | ||
| 0.086 | 0.014 | 0.086 | Phosphodiesterase 3B inhibitor | 0.078 0.015 CID_11376 | ||
| 0.093 | 0.022 | 0.1 | GABA B receptor agonist | 0.082 0.039 CID_15366 0.1 0.017 CID_11376 | CID_11376 | |
| 0.102 | 0.031 | 0.173 | Histidine decarboxylase inhibitor | 0.072 0.049 CID_15366 0.173 0.016 CID_11376 | CID_11376 | |
| 0.083 | 0.012 | 0.083 | Glutamate (mGluR group I) agonist | |||
| 0.106 | 0.036 | 0.106 | Bcr-Abl kinase inhibitor | |||
| 0.099 | 0.028 | 0.099 | Alpha adrenoreceptor agonist | |||
| 0.092 | 0.022 | 0.092 | MAP kinase kinase 10 inhibitor | |||
| 0.077 | 0.007 | 0.077 | Immunoglobulin Fc receptor antagonist | 0.056 0.034 CID_15366 0.065 0.016 CID_11376 | ||
| 0.073 | 0.004 | 0.073 | Histamine H1 receptor agonist | 0.052 0.015 CID_15366 0.043 0.032 CID_148175 0.042 0.035 CID_11376 | ||
| 0.117 | 0.049 | 0.173 | Xanthine oxidase inhibitor | 0.173 0.026 CID_11376 | CID_11376 | |
| 0.077 | 0.008 | 0.081 | Pregnane X receptor antagonist | 0.081 0.006 CID_15366 0.07 0.014 CID_11376 | CID_15366 | |
| 0.076 | 0.008 | 0.076 | Histamine H2 receptor agonist | 0.05 0.022 CID_15366 | ||
| 0.084 | 0.016 | 0.084 | Potassium channel (Ca-activated) blocker | |||
| 0.088 | 0.02 | 0.102 | Xanthine dehydrogenase inhibitor | 0.102 0.015 CID_11376 | CID_11376 | |
| 0.099 | 0.032 | 0.099 | Rho-associated kinase I inhibitor | 0.073 0.053 CID_11376 | ||
| 0.08 | 0.013 | 0.08 | H+/K+-transporting ATPase inhibitor | 0.051 0.036 CID_15366 | ||
| 0.07 | 0.004 | 0.07 | Vanilloid 3 antagonist | 0.046 0.012 CID_148175 0.046 0.012 CID_11376 | ||
| 0.091 | 0.025 | 0.091 | Vanilloid 4 agonist | 0.072 0.058 CID_15366 | ||
| 0.142 | 0.077 | 0.142 | Thiol protease inhibitor | |||
| 0.081 | 0.015 | 0.081 | Glucosylceramidase inhibitor | 0.06 0.031 CID_148175 0.055 0.038 CID_11376 | ||
| 0.093 | 0.028 | 0.093 | Neuronal nicotinic receptor antagonist | 0.092 0.028 CID_148175 0.088 0.03 CID_11376 | ||
| 0.087 | 0.022 | 0.087 | Bombesin 1 receptor agonist | |||
| 0.11 | 0.045 | 0.11 | Nitric-oxide synthase inhibitor | |||
| 0.08 | 0.015 | 0.08 | MAP kinase kinase 9 inhibitor | |||
| 0.073 | 0.008 | 0.073 | Benzodiazepine inverse agonist | 0.066 0.011 CID_15366 | ||
| 0.122 | 0.058 | 0.122 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.108 | 0.044 | 0.108 | Potassium channel (Voltage-sensitive) activator | |||
| 0.083 | 0.019 | 0.083 | Cyclin-dependent kinase 6 inhibitor | 0.063 0.038 CID_15366 | ||
| 0.092 | 0.028 | 0.092 | Fibroblast growth factor 2 antagonist | 0.063 0.049 CID_11376 | ||
| 0.08 | 0.017 | 0.095 | Nicotinic receptor alpha7 subunit antagonist | 0.095 0.013 CID_148175 | CID_148175 | |
| 0.071 | 0.008 | 0.071 | Dopamine beta hydroxylase inhibitor | 0.047 0.037 CID_15366 0.064 0.011 CID_11376 | ||
| 0.086 | 0.023 | 0.086 | Potassium channel (Tandem pore domain) blocker | |||
| 0.116 | 0.053 | 0.116 | Alpha 2c adrenoreceptor antagonist | |||
| 0.072 | 0.01 | 0.072 | Urate transporter 1 inhibitor | 0.072 0.01 CID_11376 | ||
| 0.111 | 0.049 | 0.122 | Sphingomyelinase inhibitor | 0.122 0.04 CID_148175 | CID_148175 | |
| 0.067 | 0.006 | 0.067 | Guanylate cyclase inhibitor | 0.046 0.025 CID_148175 0.057 0.014 CID_11376 | ||
| 0.067 | 0.006 | 0.067 | Protein kinase (CK1) epsilon inhibitor | 0.039 0.027 CID_11376 | ||
| 0.136 | 0.076 | 0.136 | Ribosomal protein S6 kinase inhibitor | 0.109 0.104 CID_11376 | ||
| 0.168 | 0.109 | 0.173 | Insulin sensitizer | 0.173 0.103 CID_11376 | CID_11376 | |
| 0.118 | 0.059 | 0.118 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.088 | 0.029 | 0.088 | MAP kinase kinase 8 inhibitor | |||
| 0.103 | 0.044 | 0.103 | Insulin growth factor antagonist | |||
| 0.082 | 0.024 | 0.102 | Purinergic P2X1 antagonist | 0.06 0.044 CID_15366 0.102 0.016 CID_11376 | CID_11376 | |
| 0.065 | 0.007 | 0.065 | Nerve growth factor antagonist | 0.05 0.018 CID_15366 0.05 0.018 CID_11376 | ||
| 0.099 | 0.04 | 0.099 | Acetylcholine nicotinic antagonist | 0.097 0.041 CID_148175 0.096 0.042 CID_11376 | ||
| 0.115 | 0.057 | 0.115 | Falcipain 3 inhibitor | |||
| 0.063 | 0.005 | 0.063 | Free fatty acid receptor 1 antagonist | 0.034 0.023 CID_11376 | ||
| 0.163 | 0.105 | 0.163 | Psychostimulant | 0.138 0.128 CID_11376 | ||
| 0.094 | 0.037 | 0.116 | D-Ala-D-Ala ligase inhibitor | 0.088 0.049 CID_15366 0.116 0.015 CID_11376 | CID_11376 | |
| 0.088 | 0.031 | 0.088 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.066 | 0.009 | 0.066 | Geranyltranstransferase inhibitor | 0.045 0.029 CID_11376 | ||
| 0.067 | 0.01 | 0.067 | Glutamate (mGluR group III) antagonist | 0.05 0.021 CID_15366 | ||
| 0.067 | 0.01 | 0.067 | Purinergic P2X4 antagonist | 0.042 0.041 CID_15366 0.056 0.018 CID_11376 | ||
| 0.139 | 0.083 | 0.139 | Neuropeptide Y1 antagonist | |||
| 0.076 | 0.019 | 0.076 | Dihydroorotate dehydrogenase inhibitor | 0.063 0.026 CID_11376 | ||
| 0.111 | 0.055 | 0.111 | Platelet activating factor beta antagonist | |||
| 0.114 | 0.058 | 0.114 | Granulocyte macrophage colony stimulating factor antagonist | 0.105 0.066 CID_15366 | ||
| 0.066 | 0.01 | 0.066 | GABA B receptor antagonist | 0.045 0.026 CID_11376 | ||
| 0.094 | 0.038 | 0.094 | MAP kinase 10 inhibitor | |||
| 0.096 | 0.04 | 0.096 | Catalase inhibitor | 0.068 0.056 CID_15366 | ||
| 0.093 | 0.037 | 0.093 | Raf kinase inhibitor | |||
| 0.078 | 0.022 | 0.168 | Phosphodiesterase 4C inhibitor | 0.168 0.005 CID_15366 | CID_15366 | |
| 0.085 | 0.03 | 0.085 | Protein kinase C alpha inhibitor | |||
| 0.089 | 0.034 | 0.089 | Syk tyrosine kinase inhibitor | 0.067 0.052 CID_11376 | ||
| 0.112 | 0.057 | 0.112 | MAO A inhibitor | 0.092 0.07 CID_11376 | ||
| 0.077 | 0.023 | 0.089 | Heat shock protein 90 beta antagonist | 0.064 0.034 CID_148175 0.089 0.015 CID_11376 | CID_11376 | |
| 0.081 | 0.027 | 0.081 | Aromatase inhibitor | 0.079 0.028 CID_11376 | ||
| 0.214 | 0.16 | 0.214 | Antithrombotic | 0.194 0.185 CID_15366 0.202 0.175 CID_148175 | ||
| 0.085 | 0.031 | 0.085 | Secretase beta inhibitor | 0.075 0.042 CID_11376 | ||
| 0.072 | 0.018 | 0.072 | Histamine agonist | |||
| 0.101 | 0.047 | 0.124 | Antineoplastic alkaloid | 0.124 0.036 CID_11376 | CID_11376 | |
| 0.126 | 0.072 | 0.194 | Toll-Like receptor 2 antagonist | 0.194 0.026 CID_11376 | CID_11376 | |
| 0.058 | 0.005 | 0.058 | Protein kinase (CK2) beta inhibitor | 0.055 0.006 CID_11376 | ||
| 0.091 | 0.038 | 0.091 | Telomerase inhibitor | |||
| 0.071 | 0.017 | 0.071 | Nicotinic alpha3beta2 receptor antagonist | 0.055 0.033 CID_11376 | ||
| 0.097 | 0.044 | 0.097 | Insulin like growth factor 1 antagonist | |||
| 0.112 | 0.059 | 0.119 | Interleukin 2 antagonist | 0.119 0.047 CID_148175 | CID_148175 | |
| 0.123 | 0.07 | 0.123 | Nav1.3 sodium channel blocker | |||
| 0.099 | 0.047 | 0.099 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.095 0.051 CID_11376 | ||
| 0.1 | 0.048 | 0.263 | Potassium channel activator | 0.263 0.005 CID_15366 | CID_15366 | |
| 0.085 | 0.033 | 0.187 | Phosphodiesterase 4B inhibitor | 0.187 0.009 CID_15366 0.063 0.053 CID_11376 | CID_15366 | |
| 0.09 | 0.038 | 0.114 | CC chemokine 5 receptor agonist | 0.114 0.011 CID_15366 0.095 0.028 CID_11376 | CID_15366 | |
| 0.092 | 0.04 | 0.092 | Phosphodiesterase XI inhibitor | |||
| 0.092 | 0.04 | 0.092 | Phosphodiesterase 11A inhibitor | |||
| 0.109 | 0.057 | 0.109 | Urease inhibitor | 0.095 0.072 CID_15366 0.1 0.067 CID_11376 | ||
| 0.106 | 0.054 | 0.172 | MAP kinase 8 inhibitor | 0.172 0.022 CID_15366 | CID_15366 | |
| 0.131 | 0.08 | 0.131 | Aurora-C kinase inhibitor | |||
| 0.126 | 0.076 | 0.126 | Nav1.2 sodium channel blocker | |||
| 0.068 | 0.018 | 0.068 | Potassium channel (Inward rectifier) blocker | 0.066 0.02 CID_15366 | ||
| 0.117 | 0.067 | 0.117 | Cholesterol synthesis inhibitor | 0.106 0.08 CID_148175 0.11 0.075 CID_11376 | ||
| 0.054 | 0.005 | 0.054 | Nicotinic alpha3beta4 receptor agonist | 0.032 0.018 CID_15366 0.029 0.022 CID_148175 0.037 0.012 CID_11376 | ||
| 0.098 | 0.048 | 0.098 | Acetylcholine agonist | 0.079 0.067 CID_11376 | ||
| 0.075 | 0.026 | 0.075 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.068 | 0.019 | 0.068 | Thromboxane synthase inhibitor | 0.05 0.049 CID_15366 0.055 0.037 CID_148175 0.05 0.047 CID_11376 | ||
| 0.073 | 0.024 | 0.073 | Histone deacetylase SIRT3 inhibitor | 0.063 0.041 CID_11376 | ||
| 0.089 | 0.041 | 0.089 | Fibroblast growth factor 3 antagonist | |||
| 0.074 | 0.025 | 0.12 | Carbonic anhydrase VB inhibitor | 0.12 0.012 CID_15366 0.057 0.037 CID_11376 | CID_15366 | |
| 0.076 | 0.027 | 0.076 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.094 | 0.046 | 0.094 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.054 | 0.006 | 0.054 | Transforming growth factor beta 2 antagonist | |||
| 0.083 | 0.035 | 0.083 | MAP kinase 7 inhibitor | 0.074 0.07 CID_11376 | ||
| 0.093 | 0.045 | 0.093 | AXL receptor tyrosine kinase inhibitor | |||
| 0.118 | 0.07 | 0.118 | Alkylator | 0.101 0.087 CID_15366 0.112 0.076 CID_11376 | ||
| 0.058 | 0.01 | 0.058 | Orexin receptor 2 antagonist | |||
| 0.075 | 0.028 | 0.075 | Argininosuccinate synthase inhibitor | 0.061 0.036 CID_15366 0.07 0.03 CID_11376 | ||
| 0.092 | 0.046 | 0.092 | I kappa B kinase inhibitor | |||
| 0.061 | 0.015 | 0.061 | CDK5/p25 inhibitor | |||
| 0.121 | 0.074 | 0.167 | c-Src kinase inhibitor | 0.167 0.047 CID_148175 | CID_148175 | |
| 0.074 | 0.028 | 0.074 | MDM2 inhibitor | |||
| 0.055 | 0.009 | 0.055 | MAP3K5 inhibitor | 0.042 0.022 CID_11376 | ||
| 0.076 | 0.03 | 0.076 | Carbamoyl phosphate synthetase inhibitor | 0.053 0.051 CID_15366 0.071 0.034 CID_11376 | ||
| 0.063 | 0.017 | 0.063 | Histamine H4 receptor antagonist | |||
| 0.126 | 0.081 | 0.126 | Tyrosine-protein kinase receptor antagonist | |||
| 0.054 | 0.009 | 0.054 | Heme oxygenase inhibitor | 0.044 0.027 CID_15366 0.045 0.023 CID_11376 | ||
| 0.092 | 0.047 | 0.092 | Hematopoietic | |||
| 0.07 | 0.025 | 0.07 | Bombesin 3 receptor antagonist | |||
| 0.061 | 0.016 | 0.061 | Dihydroorotase inhibitor | 0.05 0.024 CID_11376 | ||
| 0.084 | 0.039 | 0.091 | Phosphofructokinase-1 inhibitor | 0.067 0.05 CID_15366 0.064 0.053 CID_148175 0.091 0.036 CID_11376 | CID_11376 | |
| 0.115 | 0.071 | 0.115 | TRKA antagonist | |||
| 0.049 | 0.005 | 0.049 | MAP3K8 inhibitor | 0.038 0.008 CID_15366 0.036 0.009 CID_11376 | ||
| 0.095 | 0.052 | 0.095 | Polo-like kinase-1 inhibitor | |||
| 0.065 | 0.022 | 0.065 | Lysine-specific demethylase 1A inhibitor | 0.06 0.028 CID_11376 | ||
| 0.143 | 0.1 | 0.214 | Interleukin 6 antagonist | 0.214 0.033 CID_148175 | CID_148175 | |
| 0.065 | 0.022 | 0.065 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.133 | 0.091 | 0.133 | Hemostatic | |||
| 0.068 | 0.026 | 0.068 | Neuropeptide Y5 antagonist | |||
| 0.101 | 0.06 | 0.101 | Insulin receptor antagonist | |||
| 0.072 | 0.03 | 0.072 | I kappa B kinase 2 inhibitor | |||
| 0.055 | 0.013 | 0.055 | TRPM8 blocker | |||
| 0.047 | 0.007 | 0.047 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.02 CID_11376 | ||
| 0.069 | 0.029 | 0.069 | Calcium channel P-type blocker | 0.068 0.033 CID_15366 0.062 0.05 CID_11376 | ||
| 0.047 | 0.007 | 0.047 | Kynurenine 3 monooxygenase inhibitor | 0.03 0.015 CID_11376 | ||
| 0.065 | 0.025 | 0.071 | mTOR inhibitor | 0.071 0.022 CID_11376 | CID_11376 | |
| 0.043 | 0.004 | 0.043 | Alpha 2b adrenoreceptor agonist | 0.019 0.014 CID_11376 | ||
| 0.055 | 0.016 | 0.055 | Glutamate (mGluR4) antagonist | 0.047 0.024 CID_15366 | ||
| 0.043 | 0.004 | 0.043 | Glucosylceramidase stimulant | 0.028 0.018 CID_15366 | ||
| 0.082 | 0.043 | 0.092 | Glutamate decarboxylase inhibitor | 0.092 0.035 CID_11376 | CID_11376 | |
| 0.097 | 0.058 | 0.097 | Potassium channel (Ca-activated) activator | 0.079 0.076 CID_15366 0.091 0.063 CID_11376 | ||
| 0.083 | 0.044 | 0.083 | Rho-associated kinase inhibitor | |||
| 0.148 | 0.109 | 0.267 | Amyloid beta aggregation inhibitor | 0.267 0.053 CID_11376 | CID_11376 | |
| 0.048 | 0.009 | 0.048 | ATM kinase inhibitor | |||
| 0.064 | 0.025 | 0.064 | 5 Hydroxytryptamine 7 agonist | 0.057 0.036 CID_11376 | ||
| 0.048 | 0.01 | 0.051 | CF transmembrane conductance regulator antagonist | 0.046 0.013 CID_15366 0.051 0.008 CID_11376 | CID_11376 | |
| 0.044 | 0.006 | 0.044 | 5 Hydroxytryptamine 6 agonist | 0.027 0.024 CID_15366 | ||
| 0.09 | 0.052 | 0.09 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.042 | 0.004 | 0.042 | Alpha 2a adrenoreceptor agonist | 0.034 0.005 CID_148175 0.02 0.009 CID_11376 | ||
| 0.052 | 0.014 | 0.052 | Diamine oxidase inhibitor | |||
| 0.088 | 0.05 | 0.125 | Histamine H1 receptor antagonist | 0.125 0.03 CID_15366 | CID_15366 | |
| 0.043 | 0.006 | 0.043 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.015 CID_15366 0.04 0.008 CID_11376 | ||
| 0.059 | 0.021 | 0.07 | Potassium channel (Inward rectifier) activator | 0.07 0.012 CID_15366 | CID_15366 | |
| 0.046 | 0.009 | 0.046 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.051 | 0.014 | 0.051 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.064 | 0.027 | 0.401 | Phosphodiesterase 4A inhibitor | 0.401 0.004 CID_15366 | CID_15366 | |
| 0.068 | 0.031 | 0.068 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.065 0.035 CID_11376 | ||
| 0.069 | 0.032 | 0.069 | Carbonic anhydrase stimulant | |||
| 0.057 | 0.02 | 0.057 | Smo receptor antagonist | |||
| 0.05 | 0.013 | 0.05 | DNA gyrase subunit B inhibitor | |||
| 0.063 | 0.028 | 0.063 | Sphingosine kinase 2 inhibitor | 0.058 0.034 CID_11376 | ||
| 0.077 | 0.041 | 0.077 | CDK1/cyclin B1 inhibitor | |||
| 0.051 | 0.015 | 0.053 | Glutamate (mGluR group II) antagonist | 0.053 0.014 CID_11376 | CID_11376 | |
| 0.056 | 0.021 | 0.067 | Potassium channel (ATP-sensitive) activator | 0.067 0.011 CID_15366 | CID_15366 | |
| 0.17 | 0.134 | 0.347 | Tumour necrosis factor alpha release inhibitor | 0.347 0.039 CID_15366 | CID_15366 | |
| 0.069 | 0.033 | 0.069 | Cyclin B1 inhibitor | |||
| 0.113 | 0.078 | 0.113 | Cyclin-dependent kinase inhibitor | |||
| 0.05 | 0.015 | 0.072 | Inosine monophosphate dehydrogenase inhibitor | 0.072 0.008 CID_15366 0.034 0.029 CID_11376 | CID_15366 | |
| 0.081 | 0.047 | 0.107 | Keratolytic | 0.081 0.047 CID_15366 0.107 0.027 CID_11376 | CID_11376 | |
| 0.08 | 0.045 | 0.081 | Glutamate dehydrogenase inhibitor | 0.067 0.061 CID_15366 0.081 0.044 CID_11376 | CID_11376 | |
| 0.068 | 0.033 | 0.068 | CDK9/cyclin T1 inhibitor | |||
| 0.044 | 0.01 | 0.044 | ATR kinase inhibitor | |||
| 0.1 | 0.066 | 0.1 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.157 | 0.123 | 0.157 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.071 | 0.037 | 0.071 | Glutamate (mGluR6) antagonist | 0.065 0.052 CID_15366 0.065 0.052 CID_11376 | ||
| 0.048 | 0.014 | 0.048 | Potassium channel Kv1.1 blocker | |||
| 0.07 | 0.037 | 0.07 | Glutamate (mGluR) agonist | |||
| 0.095 | 0.062 | 0.095 | Interleukin 12 antagonist | |||
| 0.064 | 0.032 | 0.064 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.054 | 0.022 | 0.054 | CC chemokine 4 receptor antagonist | |||
| 0.086 | 0.053 | 0.086 | Histamine H2 receptor antagonist | 0.081 0.063 CID_15366 | ||
| 0.094 | 0.061 | 0.094 | Alpha 2d adrenoreceptor antagonist | |||
| 0.085 | 0.054 | 0.085 | Inducible nitric-oxide synthase inhibitor | |||
| 0.056 | 0.025 | 0.056 | Adenosine deaminase inhibitor | 0.047 0.033 CID_11376 | ||
| 0.043 | 0.012 | 0.043 | AMPA 3 receptor antagonist | 0.035 0.017 CID_15366 | ||
| 0.122 | 0.091 | 0.122 | Sphingosine 1-phosphate receptor 2 antagonist | 0.122 0.092 CID_11376 | ||
| 0.035 | 0.004 | 0.035 | Cyclin T1 inhibitor | 0.024 0.008 CID_15366 0.018 0.013 CID_11376 | ||
| 0.081 | 0.051 | 0.087 | Interferon agonist | 0.087 0.042 CID_11376 | CID_11376 | |
| 0.063 | 0.033 | 0.063 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.068 | 0.038 | 0.069 | Interferon inducer | 0.069 0.036 CID_11376 | CID_11376 | |
| 0.073 | 0.043 | 0.105 | Carbonic anhydrase VA inhibitor | 0.105 0.023 CID_15366 0.061 0.058 CID_11376 | CID_15366 | |
| 0.049 | 0.019 | 0.056 | Angiotensin AT1 receptor antagonist | 0.056 0.01 CID_15366 | CID_15366 | |
| 0.061 | 0.031 | 0.061 | Cyclin B2 inhibitor | |||
| 0.039 | 0.009 | 0.039 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.103 | 0.073 | 0.263 | Chelator | 0.168 0.03 CID_15366 0.263 0.015 CID_11376 | CID_11376 | |
| 0.117 | 0.088 | 0.117 | Lck kinase inhibitor | |||
| 0.034 | 0.005 | 0.034 | Imidazoline I1 receptor antagonist | |||
| 0.066 | 0.037 | 0.066 | Raf kinase B inhibitor | |||
| 0.061 | 0.032 | 0.061 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.032 | 0.003 | 0.032 | Granulocyte colony stimulating factor receptor agonist | 0.018 0.013 CID_148175 0.021 0.006 CID_11376 | ||
| 0.047 | 0.018 | 0.047 | Vascular adhesion protein 1 inhibitor | |||
| 0.062 | 0.034 | 0.062 | Cyclin A1 inhibitor | |||
| 0.096 | 0.068 | 0.118 | Anabolic | 0.118 0.041 CID_15366 0.114 0.045 CID_11376 | CID_15366 | |
| 0.047 | 0.018 | 0.054 | Histone deacetylase 9 inhibitor | 0.054 0.014 CID_15366 | CID_15366 | |
| 0.033 | 0.005 | 0.037 | Complement factor 1s inhibitor | 0.037 0.004 CID_15366 | CID_15366 | |
| 0.158 | 0.13 | 0.158 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.059 | 0.031 | 0.085 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.085 0.014 CID_11376 | CID_11376 | |
| 0.056 | 0.028 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.053 | 0.025 | 0.053 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.037 CID_15366 0.053 0.026 CID_11376 | ||
| 0.051 | 0.024 | 0.051 | Fructose-1,6-bisphosphatase inhibitor | 0.043 0.034 CID_11376 | ||
| 0.039 | 0.012 | 0.04 | Glutamate (mGluR2) antagonist | 0.04 0.012 CID_11376 | CID_11376 | |
| 0.106 | 0.08 | 0.141 | Topoisomerase II inhibitor | 0.141 0.054 CID_11376 | CID_11376 | |
| 0.03 | 0.005 | 0.03 | Alpha 2c adrenoreceptor agonist | 0.025 0.006 CID_148175 | ||
| 0.058 | 0.033 | 0.061 | Leukotriene C antagonist | 0.061 0.027 CID_11376 | CID_11376 | |
| 0.079 | 0.054 | 0.105 | Topoisomerase II alpha inhibitor | 0.105 0.037 CID_11376 | CID_11376 | |
| 0.061 | 0.035 | 0.061 | Alpha 1 adrenoreceptor agonist | |||
| 0.061 | 0.036 | 0.061 | Protein kinase C theta inhibitor | |||
| 0.059 | 0.035 | 0.059 | Protein kinase C eta inhibitor | 0.049 0.046 CID_11376 | ||
| 0.045 | 0.02 | 0.045 | Histone deacetylase 7 inhibitor | 0.036 0.027 CID_15366 | ||
| 0.047 | 0.023 | 0.047 | Dihydrofolate reductase inhibitor | 0.041 0.036 CID_11376 | ||
| 0.045 | 0.021 | 0.072 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 CID_15366 0.05 0.015 CID_11376 | CID_15366 | |
| 0.08 | 0.056 | 0.144 | Carbonic anhydrase VI inhibitor | 0.144 0.022 CID_15366 0.088 0.049 CID_11376 | CID_15366 | |
| 0.081 | 0.057 | 0.081 | Neuropeptide Y antagonist | |||
| 0.081 | 0.058 | 0.081 | TIE antagonist | |||
| 0.071 | 0.047 | 0.071 | I kappa B kinase 1 inhibitor | |||
| 0.028 | 0.005 | 0.028 | Toll-Like receptor 8 agonist | 0.021 0.012 CID_11376 | ||
| 0.061 | 0.037 | 0.061 | EphB4 antagonist | |||
| 0.05 | 0.027 | 0.05 | Thymidylate synthase inhibitor | |||
| 0.039 | 0.016 | 0.039 | Calcium release-activated channel blocker | |||
| 0.064 | 0.041 | 0.064 | Cannabinoid CB1 receptor antagonist | |||
| 0.225 | 0.202 | 0.401 | Antibacterial | 0.401 0.076 CID_15366 0.374 0.089 CID_148175 0.295 0.14 CID_11376 | CID_15366 | |
| 0.038 | 0.015 | 0.038 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.043 | 0.02 | 0.043 | 5 Hydroxytryptamine 2B agonist | |||
| 0.054 | 0.032 | 0.054 | Chemokine receptor agonist | |||
| 0.031 | 0.009 | 0.041 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.041 0.007 CID_11376 | CID_11376 | |
| 0.075 | 0.052 | 0.075 | Acetylcholine M4 receptor antagonist | |||
| 0.065 | 0.042 | 0.065 | Cyclin A2 inhibitor | |||
| 0.046 | 0.023 | 0.047 | Liver X receptor alpha agonist | 0.047 0.022 CID_11376 | CID_11376 | |
| 0.08 | 0.057 | 0.08 | TIE-2 antagonist | |||
| 0.051 | 0.028 | 0.051 | Aldosterone antagonist | |||
| 0.132 | 0.11 | 0.159 | Melanin inhibitor | 0.159 0.071 CID_11376 | CID_11376 | |
| 0.109 | 0.088 | 0.109 | RET inhibitor | |||
| 0.033 | 0.012 | 0.033 | Purinergic P2Y15 antagonist | |||
| 0.135 | 0.114 | 0.135 | Antipruritic | |||
| 0.151 | 0.13 | 0.151 | HERG channel blocker | |||
| 0.057 | 0.036 | 0.057 | Cyclin B inhibitor | |||
| 0.052 | 0.031 | 0.052 | Adenosine A2b receptor antagonist | 0.047 0.037 CID_15366 | ||
| 0.033 | 0.012 | 0.033 | Dopamine autoreceptor agonist | |||
| 0.143 | 0.123 | 0.143 | Interleukin antagonist | |||
| 0.025 | 0.005 | 0.025 | Nicotinic alpha4 receptor agonist | 0.015 0.014 CID_15366 0.022 0.006 CID_11376 | ||
| 0.032 | 0.012 | 0.032 | Myristoyl transferase inhibitor | |||
| 0.037 | 0.017 | 0.037 | Potassium channel small-conductance Ca-activated activator | |||
| 0.069 | 0.05 | 0.069 | CXC chemokine receptor antagonist | |||
| 0.059 | 0.04 | 0.059 | Ryanodine receptor antagonist | 0.059 0.04 CID_11376 | ||
| 0.06 | 0.041 | 0.06 | Protein kinase C iota inhibitor | |||
| 0.069 | 0.05 | 0.069 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.034 | 0.016 | 0.034 | Liver X receptor beta antagonist | 0.034 0.016 CID_11376 | ||
| 0.044 | 0.026 | 0.044 | DNA-dependent protein kinase inhibitor | |||
| 0.064 | 0.046 | 0.064 | Histone deacetylase inhibitor | |||
| 0.055 | 0.037 | 0.055 | Epithelial sodium channel blocker | |||
| 0.024 | 0.006 | 0.044 | Nicotinic acid receptor 1 antagonist | 0.044 0.003 CID_11376 | CID_11376 | |
| 0.022 | 0.005 | 0.027 | Egl nine homolog 1 inhibitor | 0.027 0.004 CID_11376 | CID_11376 | |
| 0.04 | 0.023 | 0.04 | Glutamate (mGluR8) agonist | 0.037 0.029 CID_15366 0.035 0.034 CID_11376 | ||
| 0.081 | 0.064 | 0.096 | Estrogen-related receptor beta agonist | 0.096 0.03 CID_11376 | CID_11376 | |
| 0.063 | 0.045 | 0.112 | DNA gyrase inhibitor | 0.112 0.015 CID_15366 | CID_15366 | |
| 0.113 | 0.096 | 0.141 | Interleukin 4 antagonist | 0.141 0.059 CID_11376 | CID_11376 | |
| 0.042 | 0.025 | 0.071 | Dopamine D5 agonist | 0.071 0.008 CID_11376 | CID_11376 | |
| 0.039 | 0.022 | 0.039 | Glutamate (mGluR3) antagonist | |||
| 0.036 | 0.019 | 0.036 | Liver X receptor beta agonist | 0.034 0.021 CID_11376 | ||
| 0.055 | 0.039 | 0.055 | Phosphodiesterase II inhibitor | |||
| 0.022 | 0.005 | 0.029 | CC chemokine 9 receptor antagonist | 0.029 0.004 CID_15366 | CID_15366 | |
| 0.108 | 0.092 | 0.112 | Cyclooxygenase 3 inhibitor | 0.112 0.087 CID_11376 | CID_11376 | |
| 0.038 | 0.022 | 0.083 | Nicotinic acid receptor agonist | 0.083 0.006 CID_11376 | CID_11376 | |
| 0.02 | 0.004 | 0.02 | Egl nine homolog 3 inhibitor | 0.014 0.007 CID_11376 | ||
| 0.021 | 0.005 | 0.021 | CXC chemokine 4 receptor agonist | |||
| 0.047 | 0.031 | 0.047 | Adenylate cyclase 1 inhibitor | |||
| 0.086 | 0.071 | 0.103 | Uric acid excretion stimulant | 0.103 0.05 CID_11376 | CID_11376 | |
| 0.036 | 0.02 | 0.047 | Angiotensin II receptor antagonist | 0.047 0.009 CID_15366 | CID_15366 | |
| 0.165 | 0.15 | 0.165 | Spasmolytic | |||
| 0.036 | 0.021 | 0.036 | Adenosine uptake inhibitor | |||
| 0.027 | 0.012 | 0.027 | Adenosine kinase inhibitor | |||
| 0.035 | 0.02 | 0.035 | Melatonin receptor 1A agonist | 0.033 0.024 CID_11376 | ||
| 0.071 | 0.056 | 0.071 | Alpha 2a adrenoreceptor antagonist | |||
| 0.064 | 0.049 | 0.104 | Carbonic anhydrase V inhibitor | 0.104 0.026 CID_15366 | CID_15366 | |
| 0.075 | 0.06 | 0.075 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.052 | 0.038 | 0.052 | Alpha 1L adrenoreceptor antagonist | |||
| 0.079 | 0.065 | 0.128 | Thioredoxin reductase inhibitor | 0.128 0.014 CID_148175 | CID_148175 | |
| 0.024 | 0.01 | 0.024 | Apolipoprotein B inhibitor | |||
| 0.093 | 0.079 | 0.093 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.102 | 0.088 | 0.134 | Microtubule formation inhibitor | 0.134 0.048 CID_148175 0.1 0.092 CID_11376 | CID_148175 | |
| 0.044 | 0.03 | 0.073 | NMDA receptor subunit 3B antagonist | 0.073 0.015 CID_11376 | CID_11376 | |
| 0.028 | 0.015 | 0.028 | Nicotinic acid receptor 2 antagonist | 0.026 0.019 CID_15366 | ||
| 0.058 | 0.045 | 0.058 | Cyclin A inhibitor | |||
| 0.037 | 0.024 | 0.048 | Kainate receptor 2 antagonist | 0.048 0.017 CID_15366 | CID_15366 | |
| 0.114 | 0.102 | 0.12 | Vanilloid 1 agonist | 0.12 0.087 CID_11376 | CID_11376 | |
| 0.024 | 0.011 | 0.024 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.104 | 0.092 | 0.104 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.031 | 0.018 | 0.031 | Cyclin E2 inhibitor | |||
| 0.016 | 0.004 | 0.016 | Imidazoline I2 receptor antagonist | |||
| 0.039 | 0.028 | 0.045 | AMPA 4 receptor antagonist | 0.045 0.019 CID_15366 | CID_15366 | |
| 0.049 | 0.037 | 0.054 | CD45 antagonist | 0.054 0.028 CID_11376 | CID_11376 | |
| 0.061 | 0.05 | 0.061 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.06 | 0.049 | 0.06 | Adenosine A2 receptor antagonist | |||
| 0.051 | 0.04 | 0.051 | Protein kinase C epsilon inhibitor | |||
| 0.055 | 0.044 | 0.055 | Adenosine A1 receptor antagonist | |||
| 0.058 | 0.047 | 0.058 | Adenosine A2a receptor antagonist | 0.055 0.049 CID_11376 | ||
| 0.022 | 0.012 | 0.022 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.027 | 0.016 | 0.027 | Complement factor 1r inhibitor | |||
| 0.015 | 0.005 | 0.015 | Cyclin D2 inhibitor | |||
| 0.028 | 0.018 | 0.028 | Hedgehog signaling activator | |||
| 0.069 | 0.059 | 0.069 | Protein kinase B gamma inhibitor | |||
| 0.048 | 0.038 | 0.048 | Phosphodiesterase 2A inhibitor | |||
| 0.034 | 0.024 | 0.034 | CXC chemokine receptor agonist | |||
| 0.026 | 0.017 | 0.026 | Acid ceramidase inhibitor | 0.024 0.022 CID_15366 | ||
| 0.079 | 0.07 | 0.346 | T cell inhibitor | 0.346 0.005 CID_148175 | CID_148175 | |
| 0.019 | 0.01 | 0.019 | Complement factor D inhibitor | |||
| 0.1 | 0.091 | 0.102 | Caspase 3 inhibitor | 0.102 0.088 CID_11376 | CID_11376 | |
| 0.038 | 0.029 | 0.038 | GABA uptake inhibitor | 0.035 0.034 CID_11376 | ||
| 0.086 | 0.077 | 0.086 | Ephrin antagonist | |||
| 0.078 | 0.069 | 0.078 | Alpha 2 adrenoreceptor antagonist | |||
| 0.082 | 0.074 | 0.092 | Antihistaminic | 0.092 0.062 CID_15366 | CID_15366 | |
| 0.086 | 0.078 | 0.086 | Check point kinase 2 inhibitor | |||
| 0.015 | 0.008 | 0.015 | 5 Lipoxygenase activating protein inhibitor | |||
| 0.059 | 0.052 | 0.545 | p38 MAP kinase inhibitor | 0.545 0.004 CID_15366 | CID_15366 | |
| 0.025 | 0.018 | 0.025 | Prostaglandin H2 antagonist | |||
| 0.057 | 0.05 | 0.057 | 5 Hydroxytryptamine 2A agonist | |||
| 0.029 | 0.022 | 0.029 | Acetylcholine M4 receptor agonist | |||
| 0.022 | 0.015 | 0.022 | Glutamate (mGluR1a) agonist | |||
| 0.051 | 0.044 | 0.053 | Beta 1 adrenoreceptor antagonist | 0.053 0.043 CID_11376 | CID_11376 | |
| 0.041 | 0.035 | 0.041 | Guanylate cyclase stimulant | |||
| 0.081 | 0.075 | 0.081 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.124 | 0.118 | 0.124 | Polo-like kinase-3 inhibitor | |||
| 0.019 | 0.012 | 0.019 | Somatostatin 3 agonist | |||
| 0.033 | 0.027 | 0.033 | Phosphoglycerate kinase inhibitor | |||
| 0.023 | 0.016 | 0.023 | ICAM 1 antagonist | |||
| 0.019 | 0.012 | 0.019 | Histamine H4 receptor agonist | |||
| 0.087 | 0.081 | 0.093 | Bile acid receptor antagonist | 0.093 0.065 CID_11376 | CID_11376 | |
| 0.009 | 0.003 | 0.009 | CC chemokine 6 receptor agonist | |||
| 0.039 | 0.033 | 0.039 | Plasmepsin II inhibitor | |||
| 0.014 | 0.008 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.046 | 0.04 | 0.046 | Bombesin 2 receptor antagonist | |||
| 0.038 | 0.032 | 0.038 | Acid-sensing ion channel blocker | |||
| 0.034 | 0.029 | 0.034 | Delayed rectifier potassium channel activator | |||
| 0.034 | 0.029 | 0.034 | Potassium channel KCNQ activator | |||
| 0.118 | 0.112 | 0.118 | Acetylcholine M1 receptor antagonist | |||
| 0.038 | 0.033 | 0.038 | Thymidine kinase inhibitor | |||
| 0.026 | 0.021 | 0.03 | Protocollagen prolyl hydroxylase inhibitor | 0.025 0.024 CID_15366 0.03 0.015 CID_11376 | CID_11376 | |
| 0.098 | 0.093 | 0.098 | CDK3/cyclin E inhibitor | |||
| 0.024 | 0.019 | 0.024 | Glutamate (mGluR1) agonist | |||
| 0.032 | 0.028 | 0.032 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.066 | 0.062 | 0.066 | Rho-associated kinase II inhibitor | |||
| 0.046 | 0.042 | 0.046 | Squalene epoxidase inhibitor | |||
| 0.1 | 0.096 | 0.1 | Calcium channel N-type blocker | |||
| 0.046 | 0.042 | 0.046 | Prolyl endopeptidase inhibitor | |||
| 0.067 | 0.063 | 0.069 | Na+ K+ transporting ATPase inhibitor | 0.069 0.061 CID_11376 | CID_11376 | |
| 0.026 | 0.022 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.039 | 0.036 | 0.039 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.062 | 0.059 | 0.062 | Cannabinoid receptor antagonist | |||
| 0.055 | 0.052 | 0.055 | NMDA 2C receptor antagonist | 0.055 0.053 CID_11376 | ||
| 0.03 | 0.028 | 0.055 | Estrogen-related receptor beta antagonist | 0.055 0.005 CID_11376 | CID_11376 | |
| 0.024 | 0.022 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.05 | 0.048 | 0.05 | Cyclin E inhibitor | |||
| 0.024 | 0.022 | 0.024 | Thymidine phosphorylase inhibitor | |||
| 0.051 | 0.049 | 0.051 | Dihydroorotate oxidase inhibitor | |||
| 0.005 | 0.003 | 0.005 | Glucokinase regulatory protein inhibitor | |||
| 0.056 | 0.054 | 0.056 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.038 | 0.037 | 0.038 | Kainate receptor agonist | |||
| 0.037 | 0.035 | 0.039 | Leukotriene C4 antagonist | 0.039 0.027 CID_11376 | CID_11376 | |
| 0.03 | 0.029 | 0.03 | Fumarate hydratase inhibitor | |||
| 0.095 | 0.094 | 0.095 | Proteasome inhibitor | |||
| 0.017 | 0.015 | 0.017 | Apolipoprotein B-100 inhibitor | |||
| 0.081 | 0.079 | 0.081 | Breast cancer-resistant protein inhibitor | |||
| 0.074 | 0.073 | 0.074 | Glutathione S-transferase inhibitor | |||
| 0.052 | 0.051 | 0.052 | Cannabinoid CB1 receptor agonist | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.019 | 0.018 | 0.019 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.051 | 0.05 | 0.051 | Fibroblast growth factor 4 antagonist | |||
| 0.033 | 0.032 | 0.033 | G protein-coupled receptor agonist | |||
| 0.035 | 0.034 | 0.035 | Dihydropteroate synthase inhibitor | |||
| 0.072 | 0.073 | 0.083 | Histamine antagonist | 0.083 0.061 CID_15366 | CID_15366 | |
| 0.032 | 0.033 | 0.05 | Factor XIIIa inhibitor | 0.05 0.016 CID_15366 | CID_15366 | |
| 0.011 | 0.013 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | 0.015 0.006 CID_15366 | CID_15366 | |
| 0.088 | 0.09 | 0.115 | AMP-activated protein kinase stimulant | 0.115 0.053 CID_11376 | CID_11376 | |
| 0.044 | 0.047 | 0.091 | Nicotinic receptor alpha4 subunit antagonist | 0.091 0.01 CID_11376 | CID_11376 | |
| 0.026 | 0.029 | 0.029 | Estrogen-related receptor gamma antagonist | 0.029 0.018 CID_11376 | CID_11376 | |
| 0.043 | 0.048 | 0.049 | Beta 2 adrenoreceptor antagonist | 0.049 0.038 CID_11376 | CID_11376 | |
| 0.058 | 0.063 | 0.062 | Beta 3 adrenoreceptor antagonist | 0.062 0.049 CID_11376 | CID_11376 | |
| 0.061 | 0.068 | 0.115 | Carbonic anhydrase XIII inhibitor | 0.115 0.031 CID_15366 0.065 0.063 CID_11376 | CID_15366 | |
| 0.009 | 0.017 | 0.013 | Angiotensin AT1B receptor antagonist | 0.013 0.01 CID_15366 | CID_15366 | |
| 0.057 | 0.067 | 0.162 | NMDA 2 receptor antagonist | 0.162 0.014 CID_11376 | CID_11376 | |
| 0.049 | 0.059 | 0.053 | Calcium channel T-type blocker | 0.053 0.05 CID_15366 | CID_15366 | |
| 0.03 | 0.04 | 0.037 | Kainate receptor antagonist | 0.037 0.032 CID_15366 | CID_15366 | |
| 0.052 | 0.063 | 0.077 | Leukotriene antagonist | 0.077 0.034 CID_11376 | CID_11376 | |
| 0.092 | 0.103 | 0.166 | M18 aspartyl aminopeptidase inhibitor | 0.166 0.045 CID_11376 | CID_11376 | |
| 0.054 | 0.065 | 0.137 | Leukotriene synthesis inhibitor | 0.137 0.012 CID_11376 | CID_11376 | |
| 0.047 | 0.059 | 0.064 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.064 0.035 CID_11376 | CID_11376 | |
| 0.027 | 0.04 | 0.042 | NMDA receptor subunit 3A antagonist | 0.042 0.024 CID_11376 | CID_11376 | |
| 0.013 | 0.031 | 0.049 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.049 0.007 CID_11376 | CID_11376 | |
| 0.084 | 0.103 | 0.092 | mTOR complex 1 inhibitor | 0.092 0.08 CID_148175 | CID_148175 | |
| 0.038 | 0.057 | 0.84 | Dopamine D4 agonist | 0.84 0.002 CID_15366 | CID_15366 | |
| 0.035 | 0.055 | 0.091 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.091 0.018 CID_11376 | CID_11376 | |
| 0.013 | 0.033 | 0.019 | CXC chemokine 5 receptor antagonist | 0.019 0.01 CID_15366 | CID_15366 | |
| 0.045 | 0.066 | 0.059 | Androgen agonist | 0.059 0.043 CID_11376 | CID_11376 | |
| 0.064 | 0.085 | 0.092 | Estrogen receptor alpha antagonist | 0.092 0.033 CID_11376 | CID_11376 | |
| 0.044 | 0.066 | 0.083 | Phosphatidylinositol kinase inhibitor | 0.083 0.027 CID_11376 | CID_11376 | |
| 0.023 | 0.046 | 0.03 | ATP citrate lysase inhibitor | 0.03 0.025 CID_11376 | CID_11376 | |
| 0.041 | 0.067 | 0.289 | NMDA 2B receptor antagonist | 0.289 0.004 CID_11376 | CID_11376 | |
| 0.013 | 0.042 | 0.027 | NMDA receptor glycine site antagonist | 0.027 0.014 CID_15366 | CID_15366 | |
| 0.034 | 0.064 | 0.099 | Farnesyltransferase inhibitor | 0.099 0.008 CID_15366 | CID_15366 | |
| 0.097 | 0.128 | 0.144 | Protein kinase stimulant | 0.144 0.073 CID_11376 | CID_11376 | |
| 0.191 | 0.229 | 0.225 | Alpha-glucosidase inhibitor | 0.225 0.203 CID_11376 | CID_11376 | |
| 0.02 | 0.059 | 0.045 | Catechol O-methyltransferase inhibitor | 0.03 0.027 CID_15366 0.045 0.011 CID_11376 | CID_11376 | |
| 0.017 | 0.057 | 0.023 | CC chemokine 8 receptor antagonist | 0.023 0.018 CID_15366 0.023 0.018 CID_148175 | CID_148175 | |
| 0.023 | 0.063 | 0.037 | Purinergic P2X3 antagonist | 0.037 0.02 CID_15366 | CID_15366 | |
| 0.03 | 0.073 | 0.043 | Carbonic anhydrase XIV inhibitor | 0.043 0.042 CID_15366 | CID_15366 | |
| 0.022 | 0.065 | 0.069 | Estradiol 17 beta-dehydrogenase inhibitor | 0.069 0.016 CID_11376 | CID_11376 | |
| 0.059 | 0.103 | 0.126 | NMDA receptor antagonist | 0.085 0.059 CID_15366 0.126 0.033 CID_11376 | CID_11376 | |
| 0.011 | 0.056 | 0.044 | Kainate receptor 4 antagonist | 0.044 0.008 CID_15366 | CID_15366 | |
| 0.039 | 0.085 | 0.059 | Neutrophil collagenase inhibitor | 0.059 0.052 CID_15366 | CID_15366 | |
| 0.018 | 0.068 | 0.034 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.034 0.02 CID_11376 | CID_11376 | |
| 0.03 | 0.082 | 0.055 | Alpha tubulin antagonist | 0.055 0.034 CID_11376 | CID_11376 | |
| 0.02 | 0.074 | 0.126 | Somatostatin 5 agonist | 0.126 0.004 CID_148175 | CID_148175 | |
| 0.046 | 0.101 | 0.087 | Histone deacetylase SIRT2 inhibitor | 0.087 0.04 CID_11376 | CID_11376 | |
| 0.207 | 0.263 | 0.492 | Apoptosis agonist | 0.35 0.138 CID_15366 0.492 0.077 CID_148175 0.348 0.14 CID_11376 | CID_148175 | |
| 0.008 | 0.065 | 0.018 | Kainate receptor 3 antagonist | 0.018 0.011 CID_15366 | CID_15366 | |
| 0.056 | 0.115 | 0.089 | Monophenol monooxygenase inhibitor | 0.089 0.084 CID_11376 | CID_11376 | |
| 0.023 | 0.083 | 0.032 | Tubulin agonist | 0.032 0.028 CID_148175 | CID_148175 | |
| 0.032 | 0.094 | 0.097 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.097 0.015 CID_11376 | CID_11376 | |
| 0.074 | 0.14 | 0.159 | Tubulin antagonist | 0.159 0.054 CID_148175 0.154 0.056 CID_11376 | CID_148175 | |
| 0.092 | 0.163 | 0.119 | Phospholipase A2 inhibitor | 0.119 0.118 CID_11376 | CID_11376 | |
| 0.044 | 0.116 | 0.162 | MAP3K7 inhibitor | 0.162 0.009 CID_148175 | CID_148175 | |
| 0.068 | 0.145 | 0.139 | Histone deacetylase class III inhibitor | 0.139 0.053 CID_11376 | CID_11376 | |
| 0.007 | 0.085 | 0.024 | Kainate receptor 5 antagonist | 0.024 0.012 CID_15366 | CID_15366 | |
| 0.08 | 0.166 | 0.165 | Histone deacetylase SIRT1 inhibitor | 0.165 0.049 CID_11376 | CID_11376 | |
| 0.052 | 0.144 | 0.672 | Bronchodilator | 0.672 0.004 CID_15366 | CID_15366 | |
| 0.009 | 0.103 | 0.049 | Histone deacetylase 10 inhibitor | 0.049 0.012 CID_15366 | CID_15366 | |
| 0.011 | 0.106 | 0.03 | Histone deacetylase 4 inhibitor | 0.03 0.024 CID_15366 | CID_15366 | |
| 0.03 | 0.129 | 0.077 | HIV-1 reverse transcriptase inhibitor | 0.077 0.044 CID_15366 | CID_15366 | |
| 0.043 | 0.143 | 0.08 | HIV-1 integrase inhibitor | 0.08 0.038 CID_11376 | CID_11376 | |
| 0.013 | 0.119 | 0.044 | Histone deacetylase class IV inhibitor | 0.044 0.015 CID_15366 | CID_15366 | |
| 0.013 | 0.119 | 0.044 | Histone deacetylase 11 inhibitor | 0.044 0.015 CID_15366 | CID_15366 | |
| 0.011 | 0.119 | 0.034 | Potassium channel (Inward rectifier) 11 blocker | 0.034 0.003 CID_15366 | CID_15366 | |
| 0.014 | 0.125 | 0.034 | Nicotinic receptor beta4 subunit antagonist | 0.034 0.03 CID_11376 | CID_11376 | |
| 0.017 | 0.128 | 0.122 | Factor XIa inhibitor | 0.122 0.004 CID_15366 | CID_15366 | |
| 0.027 | 0.144 | 0.647 | Dopamine agonist | 0.647 0.004 CID_15366 0.072 0.043 CID_11376 | CID_15366 | |
| 0.023 | 0.14 | 0.051 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 CID_11376 | CID_11376 | |
| 0.061 | 0.179 | 0.101 | Cyclooxygenase 1 inhibitor | 0.101 0.099 CID_11376 | CID_11376 | |
| 0.076 | 0.195 | 0.145 | Cholinergic | 0.145 0.081 CID_11376 | CID_11376 | |
| 0.012 | 0.131 | 0.244 | Nicotinic acid receptor 2 agonist | 0.244 0.003 CID_11376 | CID_11376 | |
| 0.025 | 0.151 | 0.058 | Cathepsin F inhibitor | 0.058 0.006 CID_15366 | CID_15366 | |
| 0.009 | 0.145 | 0.035 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.035 0.024 CID_11376 | CID_11376 | |
| 0.051 | 0.199 | 0.147 | DNA directed RNA polymerase inhibitor | 0.147 0.025 CID_15366 | CID_15366 | |
| 0.069 | 0.219 | 0.13 | Neurotrophic factor | 0.13 0.08 CID_15366 | CID_15366 | |
| 0.096 | 0.254 | 0.651 | Vasodilator | 0.651 0.005 CID_15366 | CID_15366 | |
| 0.038 | 0.201 | 0.21 | 5-Lipoxygenase inhibitor | 0.21 0.023 CID_15366 0.084 0.076 CID_11376 | CID_15366 | |
| 0.022 | 0.185 | 0.04 | VCAM-1 antagonist | 0.04 0.025 CID_11376 | CID_11376 | |
| 0.022 | 0.186 | 0.04 | VCAM antagonist | 0.04 0.025 CID_11376 | CID_11376 | |
| 0.02 | 0.189 | 0.159 | Purinergic P2X2 antagonist | 0.159 0.009 CID_11376 | CID_11376 | |
| 0.008 | 0.183 | 0.065 | Factor XI inhibitor | 0.065 0.006 CID_15366 | CID_15366 | |
| 0.039 | 0.218 | 0.118 | Viral attachment inhibitor | 0.118 0.015 CID_15366 | CID_15366 | |
| 0.115 | 0.316 | 0.214 | Immunomodulator | 0.214 0.148 CID_148175 | CID_148175 | |
| 0.009 | 0.212 | 0.038 | Oxytocin antagonist | 0.038 0.027 CID_15366 | CID_15366 | |
| 0.068 | 0.275 | 0.648 | Antimitotic | 0.648 0.005 CID_148175 | CID_148175 | |
| 0.081 | 0.331 | 0.294 | Thioredoxin glutathione reductase inhibitor | 0.294 0.106 CID_15366 | CID_15366 | |
| 0.062 | 0.319 | 0.227 | Platelet adhesion inhibitor | 0.227 0.058 CID_11376 | CID_11376 | |
| 0.107 | 0.367 | 0.797 | Toll-Like receptor agonist | 0.797 0.005 CID_15366 | CID_15366 | |
| 0.079 | 0.341 | 0.155 | Lipocortins synthesis antagonist | 0.155 0.098 CID_11376 | CID_11376 | |
| 0.106 | 0.372 | 0.803 | Toll-Like receptor 7 agonist | 0.803 0.005 CID_15366 | CID_15366 | |
| 0.059 | 0.341 | 0.256 | Free radical scavenger | 0.256 0.066 CID_15366 0.206 0.093 CID_11376 | CID_15366 | |
| 0.005 | 0.294 | 0.243 | Kinesin-like protein 1 inhibitor | 0.243 0.004 CID_148175 | CID_148175 | |
| 0.005 | 0.294 | 0.243 | Kinesin antagonist | 0.243 0.004 CID_148175 | CID_148175 | |
| 0.099 | 0.39 | 0.237 | Sodium/bile acid cotransporter inhibitor | 0.237 0.143 CID_11376 | CID_11376 | |
| 0.141 | 0.434 | 0.476 | Antiinflammatory | 0.31 0.206 CID_15366 0.476 0.098 CID_11376 | CID_11376 | |
| 0.021 | 0.314 | 0.089 | Chemokine receptor antagonist | 0.089 0.075 CID_15366 | CID_15366 | |
| 0.011 | 0.306 | 0.051 | Growth hormone release inhibitor | 0.051 0.021 CID_148175 | CID_148175 | |
| 0.032 | 0.337 | 0.144 | Thrombolytic | 0.144 0.087 CID_15366 | CID_15366 | |
| 0.032 | 0.342 | 0.156 | Estrogen receptor beta antagonist | 0.156 0.014 CID_11376 | CID_11376 | |
| 0.032 | 0.359 | 0.057 | Heme oxygenase stimulant | 0.057 0.055 CID_11376 | CID_11376 | |
| 0.03 | 0.402 | 0.116 | Bone formation stimulant | 0.116 0.09 CID_11376 | CID_11376 | |
| 0.004 | 0.4 | 0.141 | Squalene synthetase inhibitor | 0.141 0.004 CID_148175 | CID_148175 | |
| 0.031 | 0.441 | 0.158 | Estrogen antagonist | 0.158 0.02 CID_11376 | CID_11376 | |
| 0.051 | 0.487 | 0.524 | Immunosuppressant | 0.524 0.027 CID_148175 | CID_148175 | |
| 0.038 | 0.482 | 0.193 | Antioxidant | 0.193 0.119 CID_11376 | CID_11376 | |
| 0.018 | 0.473 | 0.125 | ATPase (Vacuolar H+) inhibitor | 0.125 0.017 CID_148175 | CID_148175 | |
| 0.008 | 0.501 | 0.078 | CC chemokine receptor antagonist | 0.078 0.054 CID_15366 | CID_15366 | |
| 0.007 | 0.564 | 0.051 | CC chemokine 5 receptor antagonist | 0.051 0.035 CID_15366 | CID_15366 | |
| 0.004 | 0.615 | 0.052 | Microtubule stabilization | 0.052 0.025 CID_148175 | CID_148175 | |
| 0.013 | 0.633 | 0.169 | Anticoagulant | 0.169 0.066 CID_15366 | CID_15366 | |
| 0.004 | 0.678 | 0.131 | Antineoplastic antibiotic | 0.131 0.035 CID_148175 | CID_148175 | |
| 0.008 | 0.686 | 0.065 | Protein 50S ribosomal subunit inhibitor | 0.065 0.027 CID_148175 | CID_148175 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |